Page last updated: 2024-09-04

carbapenems and beta-lactams

carbapenems has been researched along with beta-lactams in 332 studies

Compound Research Comparison

Studies
(carbapenems)
Trials
(carbapenems)
Recent Studies (post-2010)
(carbapenems)
Studies
(beta-lactams)
Trials
(beta-lactams)
Recent Studies (post-2010) (beta-lactams)
7,3551475,2777,5791793,395

Research

Studies (332)

TimeframeStudies, this research(%)All Research%
pre-19906 (1.81)18.7374
1990's10 (3.01)18.2507
2000's92 (27.71)29.6817
2010's171 (51.51)24.3611
2020's53 (15.96)2.80

Authors

AuthorsStudies
Gotoh, N; Nishino, T1
Hoban, DJ1
Livermore, DM; Yang, Y1
Chin, NX; Neu, HC1
Hirata, T; Sawai, T; Yamaguchi, A1
Andrews, JM; Danks, G; Wise, R1
Amano, S; Ezaki, N; Inouye, S; Ito, T; Kojima, M; Kondo, Y; Miyado, HS; Nida, T; Niwa, T; Ohba, K; Sezaki, M; Shomura, T; Yamada, Y1
Brughera, M; Dayan, AD; Iatropoulos, MJ; Mazue, G; Newman, AJ; Scampini, G1
Gutmann, L; Kitzis, MD; Zhou, XY1
Matsumura, N; Minami, S; Mitsuhashi, S1
Verbist, L; Verhaegen, J1
Babini, GS; Livermore, DM; Yuan, M1
Bycroft, BW; McGowan, SJ; Salmond, GP1
Biedenbach, DJ; Gales, AC; Jones, RN; Lewis, MT; Mathai, D; Yamaguchi, K1
Hikida, M; Igarashi, A; Itahashi, K; Kitamura, M; Shiba, T1
Matsuda, K; Matsumoto, S; Matsumoto, Y; Sasaki, H; Takasugi, H; Yoshida, Y1
Nishino, T; Oh, T; Okuda, J; Otsuki, M1
Gotoh, N; Nishino, T; Okamoto, K1
Stock, I; Wiedemann, B1
Odenholt, I1
Anzic, B; Copar, A; Mesar, T; Prevec, T; Selic, L; Solmajer, T; Vilar, M1
Ashwood, MS; Brands, KM; Cameron, M; Conrad, KM; Cottrell, IF; Davies, AJ; Dolling, UH; Houghton, PG; Jobson, RB; Kennedy, DJ; Pipik, B; Reamer, RA; Reider, PJ; Williams, JM1
Goldstein, EJ2
Armstrong, SH; Hilliard, NJ; Johnson, CN; Quarles, S; Waites, KB1
Amicosante, G; Colì, A; Docquier, JD; Lombardi, G; Luzzaro, F; Perilli, M; Riccio, ML; Rossolini, GM; Toniolo, A1
Livermore, DM; Scott, GM; Sefton, AM1
Isaacs, RD; Shah, PM1
Abe, T; Bonomo, RA; Knox, JR; Mansour, TS; Nukaga, M; Venkatesan, AM1
Chambers, HF; Katayama, Y; Zhang, HZ1
Birk, K; Deutsch, P; Holland, S; Majumdar, A; Mistry, G; Muckow, J; Musson, DG; Rogers, JD; Sciberras, D; Xi, L1
Bert, F; Branger, C; Lambert-Zechovsky, N1
Hammond, ML1
Calvo, F; Canduela, MJ; Gallego, L; Martín, G; Pujana, I; Sevillano, E; Umaran, A1
Holland, S; Lin, JH; Majumdar, A; Mistry, G; Musson, D; Sahly, Y; Singh, R; Waldman, S; Wong, BK; Xu, X; Yu, S1
Arakawa, Y; Doi, Y; Kubota, T; Shibata, N; Wachino, J; Yagi, T; Yamane, K1
Cars, O; Gustafsson, I1
Mi, ZH; Wang, CX1
Ariza, J; Ayats, J; Borraz, C; Cabellos, C; Corbella, X; Doménech, A; Gudiol, F; Montero, A; Tubau, F1
Lartigue, MF; Nordmann, P; Poirel, L1
Bornand, JE; Fonseca, S; Garbino, J; Sax, H; Uçkay, I1
Brink, AJ; Feldman, C; Grolman, DC; Muckart, D; Pretorius, J; Richards, GA; Senekal, M; Sieling, W1
Huang, ST; Ko, WC; Lee, HC; Lee, NY; Liu, KH; Yan, JJ1
Mori, M1
Burgess, DS; Frei, CR; Moczygemba, LR1
Livermore, DM; Mushtaq, S; Warner, M1
Embil, JM; Gin, A; Hoban, DJ; Johanson, C; Noreddin, A; Vercaigne, L; Zhanel, GG1
Everson, L; Fineran, PC; Hughes, K; Salmond, GP; Slater, H1
Majiduddin, FK; Palzkill, T1
Deters, M; Kaever, V; Koal, T; Resch, K1
Caines, ME; Kershaw, NJ; Schofield, CJ; Sleeman, MC1
Avlamis, A; Katsandri, A; Legakis, NJ; Pantazatou, A; Papaparaskevas, J1
Engel, AE; Glass, D; Li, C; Wexler, HM1
Chen, WH; Hsueh, PR; Luh, KT1
Dalhoff, A; Echols, R; Janjic, N1
Biedenbach, DJ; Huynh, HK; Jones, RN1
Campomanes, P; Menéndez, MI; Sordo, TL1
Chuang, YC; Walther-Rasmussen, J; Yu, WL1
Falagas, ME; Horianopoulou, M; Kanellopoulou, M; Lambropoulos, S; Legakis, NJ; Tsakris, A1
Hernández, JR; Martínez-Martínez, L; Pascual, A; Romero, L; Velasco, C1
Bernander, S; Ericson, E; Fraenkel, CJ; Larsson, P; Melhus, A; Rydberg, J; Törnqvist, E; Ullberg, M1
Holzgrabe, U1
Sendzik, J; Stahlmann, R1
Donskey, CJ; Pultz, NJ; Stiefel, U1
Bronze, MS; Cooper, TW; Gibbs, WJ; Greenfield, RA2
Fraser, VJ; Fridkin, SK; Kollef, MH; Merz, LR; Warren, DK1
Dallow, JW; Hill, RL; Livermore, DM; Palepou, MF; Pike, R; Ward, ME; Warner, M; Woodford, N1
Falagas, ME; Manta, KG; Siempos, II; Vardakas, KZ1
Dilay, L; Hoban, DJ; Karlowsky, JA; Noreddin, AM; Rubinstein, E; Thomson, K; Wiebe, R; Zhanel, GG1
Bauer, F; Benca, J; Grey, E; Huttova, M; Kovac, M; Ondrusova, A; Rudinsky, B; Sramka, M1
Bauer, F; Benca, J; Beno, P; Huttova, M; Kisac, P; Kovac, M; Ondrusova, A; Rudinsky, B; Sramka, M1
Allali, S; Kernbaum, S; Naas, T; Nordmann, P1
Chen, M; Guo, P; Sun, H; Wang, H; Xu, Y; Yang, Q; Zhu, Y1
Lister, PD1
Bishara, J; Lishtzinsky, Y; Madar-Shapiro, L; Ofir, O; Samra, Z1
Mikamo, H; Shinagawa, N; Takesue, Y; Takeyama, H; Tanaka, K; Taniguchi, M; Watanabe, K; Yokoyama, T1
Cuzon, G; Demachy, MC; Naas, T; Nordmann, P1
Yoshida, A1
Nicolau, DP1
Livermore, DM1
Shah, PM2
Fritsche, TR; Jones, RN; Sader, HS1
Ip, M; Kei, HW; Lau, WC; Lee, N; Marasinghe, T; Wong, KY; You, JH1
Bush, K; Davies, TA; Flamm, RK; Shang, W2
Fukumoto, A; Hanaki, H; Kim, YP; Omura, S; Shiomi, K; Tomoda, H1
Joseph, J; Rodvold, KA1
Cai, JC; Chen, GX; Zhang, R; Zhou, HW1
Gülmez, D; Hascelik, G; Kocagoz, S; Livermore, DM; Metan, G; Mushtaq, S; Palepou, MF; Uzun, O; Woodford, N; Yakupogullari, Y1
Ida, T; Kato, Y; Maebashi, K; Sanbongi, Y; Takahata, S1
Baba, N; Gomi, S; Ohsawa, F; Takeuchi, Y; Watanabe, T; Yamada, M1
Aybey, AD; Dinleyici, EC; Durmaz, G; Erben, N; Kiremitci, A; Usluer, G; Yargic, ZA1
Appelbaum, PC; Glupczynski, Y; Lemaire, S; Olivier, A; Tulkens, PM; Van Bambeke, F1
Akita, H; Chiba, N; Hasegawa, K; Iwata, S; Nonoyama, M; Sato, Y; Sunakawa, K; Ubukata, K1
Bogaerts, P; Cuzon, G; Glupczynski, Y; Huang, TD; Naas, T; Nordmann, P1
Basso, M; Costa, SF; Gobara, S; Gomez, LB; Levin, AS; Oshiro, I; Paez, JG; Spadão, F1
Blanchet, B; Chhun, S; Jullien, V; Lanternier, F; Legrand, T; Pons, G; Rey, E; Zahar, JR1
Carey, PR; Kalp, M1
Dunne, WM; Fraser, VJ; Frye, JG; Marschall, J; Tibbetts, RJ; Warren, DK1
Haldorsen, B; Lundblad, EW; Samuelsen, O; Simonsen, GS; Sundsfjord, A1
Harada, S; Ishii, Y; Yamaguchi, K1
Lortholary, O; Martin, C; Nordmann, P; Plesiat, P; Potel, G; Zahar, JR1
Clarke, MJ; Edwards, SJ; Welton, NJ; Wordsworth, S1
Boo, TW; Crowley, B1
Brémont, S; Conroy, MC; Courvalin, P; Lambert, T; Moubareck, C1
Badal, RE; Bouchillon, SK; Hackel, M; Hawser, SP; Hoban, DJ; Johnson, JL1
Aggoune-Khinache, N; Bonnet, R; Delmas, J; Naim, M; Robin, F1
Cattoir, V; Daurel, C1
Appelbaum, PC; Credito, K; Kosowska-Shick, K1
Eagye, KJ; Nicolau, DP2
Blanchard, JS; Fan, F; Tremblay, LW1
Du, X; Ji, S; Li, L; Qi, Y; Shen, P; Wei, Z; Yu, Y1
dos Santos, RP; Goldani, LZ; Jacoby, T1
Blanca, M; Torres, MJ1
Ko, WC; Lee, CC; Wu, JJ; Yan, JJ; Yang, FC1
Benhamou, D; Figueiredo, S; Mugnier, P; Nordmann, P; Poirel, L; Seifert, H1
Chmielewski, M; Furman, B; Grzeszczyk, B; Kozioł, A; Staszewska-Krajewska, O1
Fisher, JF; Llarrull, LI; Mobashery, S; Testero, SA1
Cai, J; Liu, J; Wu, D1
Ahmed-Bentley, J; Peirano, G; Pitout, JD; Woodford, N1
Chiang, T; Colon-Urban, R; Eng, RH; Gomez, E; Huang, DB; Mariano, N; Urban, C1
Ersoy, Y; Görgeç, S; Kuzucu, C; Yetkin, F1
Hsueh, PR; Huang, WH; Ko, WC; Lee, NY; Tsui, KC1
Engler, C; Harris, P; Norton, R1
Dihmess, A; Evans, A; Fiorenza, M; Graffunder, E; Harrington, S; Lodise, TP; Martis, P; Masoud, R; McNutt, LA; Patel, N; Woo, B1
Bergerová, T; Hrabák, J; Urbásková, P; Zemlicková, H1
Curran, MD; Ludlam, HA; Shet, VG; Swayne, RL; Woodford, N1
Gastal, SL; Goldani, LZ; Gorniak Lovatto, C; Jacoby, T; Konkewicz, L; Kuplich, NM; Lisboa, T; Nagel, FM; Pires dos Santos, R; Pires Machado, D; Pires, MR1
Bordon, JM; Clark, RB; Karlowsky, JA; Master, RN; Ramirez, J1
Beović, B; Cizman, M; Kreft, S; Seme, K1
Bonomo, RA; Endimiani, A; Papp-Wallace, KM; Taracila, MA1
Sakata, H1
Cook, PP; Gooch, M; Rizzo, S1
Carmeli, Y; Crank, CW; Goff, DA; Goldstein, EJ; Graber, CJ; Lima, AL; Nicolau, DP1
Chang, SC; Chen, WC; Chen, YC; Hu, FC; Wang, JL; Wu, UI; Yang, CS1
Antunes, NT; Frase, H; Toth, M; Vakulenko, SB1
López, M; Martín, C; Rojo-Bezares, B; Sáenz, Y; Torres, C1
Bonnin, RA; Boulanger, A; Kaase, M; Nordmann, P; Poirel, L; Schrenzel, J1
Farbman, L; Leibovici, L; Paul, M; Yahav, D1
Chau, F; Fantin, B; Le, P; Lefort, A; Lepeule, R; Massias, L; Nucci, A; Ruppé, E1
Bourigault, C; Caroff, N; Corvec, S; Crémet, L; Guillouzouic, A; Juvin, ME; Lepelletier, D; Reynaud, A1
González, LJ; Vila, AJ1
Adnan, S; Kumar, S; Li, J; Lipman, J; Paterson, DL; Roberts, JA; Rudd, M1
Chiu, CH; Su, LH; Wu, TL1
DiPardo, BJ; Phelan, RM; Townsend, CA1
Antunes, NT; Frase, H; Toth, M; Vakulenko, SB; Vakulenko, V1
Cai, Y; Kwa, AL; Lee, W; Tan, TT; Tan, TY; Tang, S; Teo, J1
Chen, CC; Cheng, KC; Chiang, SR; Chiu, YH; Chuang, YC; Ko, WC; Ku, YH; Tang, HJ; Zhang, CC1
Aleo, A; Bonura, C; Brunelli, T; Degl'Innocenti, R; Fasciana, T; Mammina, C; Nastasi, A; Pesavento, G1
Alves, MS; Araújo, S; Azevedo, JS; Chouchani, C; Correia, A; Henriques, IS; Pereira, A1
Chen, YH; Chen, YS; Chuang, YC; Ho, CM; Ho, MW; Hsueh, PR; Huang, CC; Ko, WC; Lee, YL; Liu, CE; Liu, YC; Liu, YM; Lu, PL; Tang, HJ; Toh, HS; Wang, JH; Yu, KW1
Chen, YH; Chen, YS; Chuang, YC; Ho, CM; Hsueh, PR; Huang, CC; Ko, WC; Lee, YL; Liu, CE; Liu, YC; Liu, YM; Lu, PL; Ni, Y; Tang, HJ; Toh, HS; Wang, JH; Xu, Y; Yu, KW2
Bebrone, C; Bennink, S; Bogaerts, P; Delbrück, H; Galleni, M; Glupczynski, Y; Hoffmann, KM; Kupper, MB; Rezende de Castro, R1
McDougall, DA; Morton, AP; Playford, EG1
Colakoğlu, S; Durmaz, S; Ekincioğlu, P; Perçin, D1
de la Peña, S; Fernández-Soria, VM; Gómez-Gil, R; Gomez-Puertas, P; López-Camacho, E; Lusa-Bernal, S; Mingorance, J; Ramos-Ruiz, R; Ruiz-Carrascoso, G; Wesselink, JJ1
Barszcz, B; Cielecka-Piontek, J; Lewandowska, K; Paczkowska, M1
Crandon, JL; Hagihara, M; Nicolau, DP; Urban, CM1
Belmonte, O; Boyer, S; Camiade, S; Nordmann, P; Poirel, L; Potron, A; Rondinaud, E1
Patel, V; Rodriguez, C; Singhal, T; Soman, R; Trivedi, M1
Falagas, ME; Kapaskelis, A; Tansarli, GS; Vardakas, KZ1
Berendsen, BJ; Gerritsen, HW; Lameris, S; Nielen, MW; Stolker, AA; van Sebille, R; Wegh, RS1
Baziaka, F; Galani, L; Giamarellou, H; Karaiskos, I1
Chen, L; Liu, S; Lu, Z; Schwarz, S; Si, W; Wang, XM; Yu, S; Zhang, RM; Zhang, WJ1
Debets-Ossenkopp, Y; Murk, JL; Vainio, S; van Doorn-Schepens, M; Vandenbroucke-Grauls, C; Wilhelm, A1
Falagas, ME; Kapaskelis, A; Karageorgopoulos, DE; Tansarli, GS1
Crandon, JL; Hagihara, M; Nicolau, DP; Urban, C1
Adler, M; Cars, O; Löwdin, E; Sandegren, L; Tängdén, T1
Chmielewski, M; Furman, B; Grzeszczyk, B; Mucha, Ł; Staszewska-Krajewska, O; Stecko, S1
Falagas, ME; Ikawa, K; Tansarli, GS; Vardakas, KZ1
Gupta, N; Rodrigues, C; Shetty, A; Soman, R1
Caio, C; Ceccarelli, G; Falcone, M; Giordano, A; Mezzatesta, ML; Stefani, S; Venditti, M1
Castanheira, M; Deshpande, LM; Farrell, SE; Jones, RN; Mendes, RE1
Crandon, JL; Nicolau, DP; Nordmann, P; Wiskirchen, DE3
Arthur, M; Cordillot, M; Dubée, V; Dubost, L; Hugonnet, JE; Mainardi, JL; Marie, A; Triboulet, S1
Bodro, M; Boix, L; Calvo, M; Carratalà, J; Contra, A; Domingo-Domenech, E; Garcia-Vidal, C; Gudiol, C; Tubau, F1
Chlebicki, MP; Kwa, AL; Lee, AL; Lee, W; Liew, LT; Lim, CL; Nah, SC; Wan, CN1
Bethel, CR; Bonomo, RA; Bou, G; Desarbre, E; Fernández, A; Gatta, JA; Hujer, AM; Mallo, S; Page, MG; Papp-Wallace, KM; Smith, KM; Taracila, MA; Xu, Y1
Chen, Z; Kang, M; Li, D; Tao, C; Wang, T; Xie, Y1
Farrell, R; Kopacz, J; Mariano, N; Piracha, N; Prasad, N; Segal-Maurer, S; Shakil, J; Tarasuk, A; Urban, C; Wang, G1
Kirikae, T; Miyoshi-Akiyama, T; Shimada, K; Tada, T1
Cannon, JP; Clark, NM; Grim, SA; Lee, TA; Setlak, P1
Barth, AL; da Silva, RC; Dalarosa, MG; Falci, DR; Luz, DI; Magagnin, CM; Ribeiro, VB; Rozales, FP; Sampaio, JM; Vieira, FJ; Zavascki, AP1
Kim, HJ; Kim, MJ; Lee, SE; Sohn, JW; Yang, KS; Yoon, YK1
Badal, RE; Biedenbach, DJ; Bouchillon, SK; Hackel, M; Hoban, DJ; Nga, TT; Phuong, DM; Phuong, NT; Phuong, TT1
Chang, M; Fishovitz, J; Hermoso, JA; Mobashery, S1
Bhattacharyya, RP; Hung, DT; Wivagg, CN1
Amicosante, G; Bellio, P; Bottoni, C; Brisdelli, F; Celenza, G; Di Pietro, L; Mancini, A; Perilli, M; Sabatini, A; Segatore, B1
Danishuddin, M; Faheem, M; Khan, A; Khan, AU1
Hong, MK; Jeon, JH; Jo, JY; Kang, LW; Karim, AM; Kim, JH; Ko, KS; Lee, JH; Lee, JJ; Lee, SH; Park, KS1
Black, DJ; Frase, H; Smith, CA; Stewart, NK; Vakulenko, SB1
Bai, KJ; Chang, FY; Chen, RJ; Chen, YH; Chen, YS; Hsu, CW; Hsueh, PR; Jean, SS; Ko, WC; Lee, WS; Liao, CH; Liu, CY; Liu, JW; Lu, MC; Wu, JJ; Yu, KW1
Daitch, V; Farbman, L; Lador, A; Leibovici, L; Paul, M; Tredler, Z; Zusman, O1
Lastra, Vde L; Pinto, ME; Rivas, LM; Silva, F; Ulloa, MT; Vidal, M1
Barreto, JN; Tosh, PK; Vasoo, S1
Carlson, EE; Kocaoglu, O; Tsui, HC; Winkler, ME1
Amicosante, G; Bottoni, C; Celenza, G; Colapietro, M; Compagnoni, C; Marcoccia, F; Maturo, MG; Perilli, M; Sabatini, A; Segatore, B1
Eslami, G; Langaee, T; Rafati, M; Rafiei, A; Rezai, MS; Salehifar, E; Shafahi, K1
Blaszczyk, AJ; Booker, SJ; Buller, AR; Grove, TL; Lloyd, EP; Marous, DR; Moshos, KA; Townsend, CA1
Kaushik, A; Lamichhane, G; Makkar, N; Pandey, P; Parrish, N; Singh, U1
Artichowicz, W; Fudala-Ksiazek, S; Kotlarska, E; Luczkiewicz, A; Tarasewicz, K1
Anupurba, S; Banerjee, T; Filgona, J1
Cprek, JB; Gallagher, JC1
Arora, R; Chakotiya, AS; Chawla, R; Goel, R; Narula, A; Sharma, RK; Tanwar, A; Thakur, P1
Ji, S; Li, C; Li, S; Liang, X; Zhang, F; Zhu, Y1
Cipolla, A; D'Abramo, A; De Angelis, M; Favaro, M; Ferretti, G; Gizzi, F; Iannetta, M; Mascellino, MT; Mastroianni, CM; Oliva, A; Russo, G; Vullo, V1
Akova, M; Almela, M; Almirante, B; Bermejo, J; Bonomo, RA; Bou, G; Calbo, E; Carmeli, Y; Cisneros, JM; García-Vázquez, E; Gasch, O; Giamarellou, H; Gracia-Ahulfinger, I; Gutiérrez-Gutiérrez, B; Hamprecht, A; Hsueh, PR; Lowman, W; Martínez-Martínez, L; Mora-Rillo, M; Oliver, A; Origüen, J; Pascual, A; Paterson, DL; Peña, C; Pérez, F; Pintado, V; Pitout, J; Prim, N; Rodríguez-Baño, J; Schwaber, MJ; Tacconelli, E; Tumbarello, M; Venditti, M; Viale, P1
Damer, KM; Roman, C; Solh, T1
Centis, R; D'Ambrosio, L; Dore, S; Esposito, S; Migliori, GB; Sotgiu, G; Spanevello, A; Tiberi, S1
Aktaş, Z; Akyön, Y; Aşçı Toraman, Z; Ay, S; Ayaş, R; Aydemir, Ş; Aydın, F; Bakıcı, Z; Bayramoğlu, G; Baysallar, M; Büyüktaş, A; Çağatay, M; Çakar, A; Çelik, C; Çöplü, N; Dündar, D; Erçal, BD; Güdücüoğlu, H; Gülay, Z; Günaydın, M; Gür, D; Hasdemir, U; Karatuna, O; Kayacan, Ç; Kılıç, A; Kılıç, H; Öğünç, D; Özhak Baysan, B; Parlak, M; Tünger, A; Yanık, K; Zer, Y1
Akova, M; Almela, M; Almirante, B; Bermejo, J; Bonomo, RA; Bou, G; Calbo, E; Carmeli, Y; de Cueto, M; Gasch, O; Giamarellou, H; Gutiérrez-Gutiérrez, B; Hamprecht, A; Hernández, A; Hsueh, PR; Lowman, W; Martínez-Martínez, L; Molina, J; Mora-Rillo, M; Natera, C; Oliver, A; Origüen, J; Pascual, A; Paterson, DL; Peña, C; Pérez, F; Pérez-Galera, S; Pintado, V; Pitout, J; Prim, N; Rodríguez-Baño, J; Salamanca, E; Schwaber, MJ; Souli, M; Tacconelli, E; Tumbarello, M; Venditti, M; Viale, P1
Hu, Q; Hu, Y; Lin, X; Lv, H; Xu, X; Zhang, R1
Burgers, PC; Dekker, LJ; Goessens, WH; Kostzrewa, M; Luider, TM; Monteferrante, CG; Peer, M; Sparbier, K; Sultan, S; Ten Kate, MT1
Arai, K; Kashiwa, M; Nagano, N; Saito, R; Yamada, K1
Furuyama, T; Hanson, ND; Ishii, Y; Nonomura, H; Shimizu-Ibuka, A1
Essaied, W; Garrouste-Orgeas, M; Ruckly, S; Schwebel, C; Timsit, JF; Weiss, E; Zahar, JR1
Chmielewski, M; Furman, B; Pieczykolan, M; Staszewska-Krajewska, O1
Dinic, M; Kocic, B; Mitic, R; Mladenovic-Antic, S; Petrovic, J; Randjelovic, G; Velickovic-Radovanovic, R1
Badal, RE; Biedenbach, DJ; Giao, PT; Hung Van, P; Phuong, DM; Su Minh Tuyet, N; Thi Thanh Nga, T; Vu Trung, N1
Álvarez, C; Ardila, N; Ariza, B; Caro, MA; Gil, F; González, PF; Valderrama, SL1
Bontron, S; Nordmann, P; Poirel, L1
Li, M; Skalweit, MJ1
Leonard, DA; Peng, JW; Staude, MW1
Bomfim, MR; Coqueiro, MM; de Jesus Gomes Turri, R; Marques, AC; Marques, SG; Monteiro, AS; Monteiro, SG; Monteiro-Neto, V; Ribeiro, PC; Santos, SG1
Hackel, MA; Hoban, DJ; Karlowsky, JA; Lob, SH; Sahm, DF1
Schneider, G; Schnell, R; Steiner, EM1
Biswal, S; Ghosh, AS; Issa, B; Kar, D; Kumar, G1
Lavigne, JP; Meiller, E; Merens, A; Nicolas-Chanoine, MH; Pantel, A; Robert, J1
Alp, E; Badal, R; Gulay, Z; Koksal, I; Korten, V; Lob, S; Mete, B; Mulazimoglu, L; Oguz, VA; Tabak, F; Unal, S; Yilmaz, G; Zarakolu, P1
Bhattacharjee, A; Chakravarty, A; Choudhury, NA; Dhar, D; Ingti, B; Maurya, AP; Paul, D1
Kwon, DH; Lee, S; Razqan, GS1
Ajao, AO; Albrecht, JS; Furuno, JP; Harris, AD; Johnson, JK; Pineles, LL; Robinson, GL; Thom, KA; Zhao, L1
Jitmuang, A; Kiratisin, P; Rattanaumpawan, P; Thamlikitkul, V; Werarak, P1
Fisher, S; Galanis, C; Gupta, C; Kaushik, A; Lamichhane, G; Parrish, N; Story-Roller, E1
D'Arcy, S; Doumith, M; Findlay, J; Hopkins, KL; Howe, R; Mather, B; Meunier, D; Mustafa, N; Pike, R; Woodford, N; Wootton, M1
Fakhar, Z; Govender, T; Honarparvar, B; Kruger, HG; Lamichhane, G; Maguire, GEM; Walker, RC1
Falagas, ME; Kofteridis, DP; Maraki, S; Mavromanolaki, VE; Perdikis, D; Samonis, G; Vardakas, KZ1
Basta, LAB; Bianchet, MA; Kumar, P; Lamichhane, G; Lloyd, EP; Mattoo, R; Pan, YH; Saavedra, H; Townsend, CA1
Brunelle, JL; Kaushik, A; Kumar, P; Lamichhane, G; Lloyd, EP; Mattoo, R; Townsend, CA1
Al-Ahmad, M; Rodriguez-Bouza, T1
Abdala, E; Akova, M; Álvarez, R; Cano, A; Carratalà, J; Cervera, C; Clemente, WT; Freifeld, A; Gómez, L; Gottlieb, T; Gudiol, C; Gurguí, M; Herrera, F; Maestro-de la Calle, G; Manzur, A; Martín-Dávila, P; Maschmeyer, G; Meije, Y; Montejo, M; Peghin, M; Rodríguez-Baño, J; Royo-Cebrecos, C; Ruiz-Camps, I; Sukiennik, TC; Tebe, C1
Al-Hasan, MN; Albrecht, HA; Bookstaver, PB; Hammer, KL; Justo, JA; Kohn, J; Nimmich, EB; Smith, TJ; Troficanto, C1
Andrews, B; Bifulco, N; Carter, NM; Chen, B; Comita-Prevoir, J; de Jonge, B; Durand-Réville, TF; Ehmann, DE; Gao, N; Giacobbe, RA; Guler, S; Huynh, H; Lahiri, S; McLaughlin, R; McLeod, SM; Miller, AA; Moussa, SH; Mueller, JP; Newman, JV; O'Donnell, J; Olivier, NB; Palmer, T; Shapiro, AB; Thresher, J; Tommasi, RA; Velez-Vega, C1
Antonelli, M; Arcadipane, A; Capitanio, G; Cutuli, SL; De Pascale, G; Di Carlo, D; Di Gravio, V; Di Stefano, R; Martucci, G; Montini, L; Panarello, G; Polidori, P; Spanu, T; Vallecoccia, MS1
Martin, NI; Tehrani, KHME1
Grant, M; Holt, S; Thompson-Brazill, KA1
Kim, JH; Kim, MJ; Kim, SB; Sohn, JW; Suh, JW; Yang, KS; Yoon, YK1
Achard, MES; Anderson, GJ; Djoko, KY; Hancock, SJ; Harris, PN; Lo, AW; McEwan, AG; Miraula, M; Mitić, N; Paterson, DL; Peters, KM; Phan, MD; Prombhul, S; Schembri, MA; Schenk, G; Shafer, WM; Sidjabat, HE; Walsh, TR1
Eumkeb, G; Evans, K; Hobbs, G; Nakouti, I; Teethaisong, Y1
Horvath, E; Kazmierczak, KM; Sahm, DF; Wise, MG; Young, K1
Gupta, S; Mukhopadhyay, C; Pathak, A; Prasad, KN; Rahman, M; Rai, RP; Singh, A; Singh, S1
Jett, R; Lopez, J; O'Donnell, JN; Rhodes, NJ; Scheetz, MH1
Keshri, V; Levasseur, A; Panda, A; Pontarotti, P; Raoult, D; Rolain, JM1
Li, Y; Liu, J; Liu, Y; Shen, L; Yu, J; Zhu, W1
Kamps, JJAG; Lohans, CT; Rabe, P; Schofield, CJ1
Kanehisa, M1
Bonnin, RA; Dabos, L; Fortineau, N; Iorga, BI; Jousset, AB; Naas, T; Retailleau, P; Zavala, A1
Guo, Q; Hu, F; Li, Y; Su, J; Wang, M; Wu, S; Xu, S1
Bertrand, X; Boyer, A; Coppry, M; Dubois, V; Dumartin, C; Jeanne-Leroyer, C; Noize, P; Rogues, AM1
Naber, KG; Wagenlehner, FME1
Galani, I; Giamarellou, H; Karaiskos, I; Souli, M1
Ammerman, NC; Kaushik, A; Kreiswirth, BN; Lamichhane, G; Lee, J; Martins, O; Nuermberger, EL; Parrish, NM1
Fukushima, Y; Hiyama, Y; Masumori, N; Nakajima, C; Sato, T; Shinagawa, M; Suzuki, Y; Takahashi, S; Yokota, SI1
Bobola, V; Forbes, W; Frazier, W; Joyner, ML; Manning, CC1
Li, WJ; Maruthupandy, M; Quero, F; Rajivgandhi, G; Veeramani, T1
Bragginton, EC; Colenso, CK; Hinchliffe, P; Hirvonen, VHA; Spencer, J; Takebayashi, Y; Tooke, CL1
Al-Bustan, SA; Alkhudhairy, MK; Alshadeedi, SMJ; Ghasemian, A; Mahmood, SS1
Alfonso, C; Berger, MA; Cejas, D; De Paulis, A; Elena, A; Fernández-Canigia, L; Guevara Nuñez, D; Gutkind, G; Magariños, F; Radice, M; Sevillano Platero, P1
Dean, CR; Ke, X; Lopez, SL; McEnroe, G; Ranjitkar, S; Reck, F; Zhu, Q1
Akata, K; Kawanami, T; Kido, T; Mukae, H; Muratani, T; Naito, K; Noguchi, S; Yamasaki, K; Yatera, K1
Jang, SM; Mueller, BA; Pai, MP; Shaw, AR1
DeShong, P; Ganapati, S; Nanayakkara, IA; Nguyen, HT; Watts, D; White, IM1
Higuita-Gutiérrez, LF; Jiménez-Quiceno, JN; Vargas-Alzate, CA1
Nishida, S; Ono, Y1
Caroline, C; Chien-Boon Lye, D; Choon-Kiat Tan, N; Ding, YY; Hsien-Xiong Lee, R; Lim, JP; Neo, HY; Pei-Ying Ho, E; Tan, KT; Wei-Han Ng, D1
Choi, J; Dantas, G; Das, S; Gandra, S; Green, SJ; Harazin, M; McElvania, E; Singh, KS; Thomson, RB1
Barth, AL; Basso, KB; Bonomo, RA; Boyce, JD; Bulitta, JB; Deveson Lucas, D; Drusano, GL; Jiao, Y; Kim, TH; Lang, Y; Lee, RE; Louie, A; Moya, B; Reeve, SM; Schweizer, HP; Shin, BS; Sutaria, DS; Tao, X; Zavascki, AP; Zhou, J1
Bostock, MJ; Fino, R; Kolonko, M; Mejdi-Nitiu, R; Meyer, H; Popowicz, GM; Sattler, M; Softley, CA; Zak, KM; Zhou, RX1
Craft, DW; England, MR; Hale, CM; Lesher, MD; Myers, DS; Wijetunge, DSS1
Carter, NM; McLeod, SM; Miller, AA; Moussa, SH; Mueller, JP; Shapiro, AB; Tommasi, R1
Bonsall, TJ; Miller, CL; Wilhelm, NB1
Berthomieu, D; De Luca, F; Docquier, JD; Feller, G; Galleni, M; Gavara, L; Gresh, N; Hernandez, JF; Legru, A; Marcoccia, F; Mercuri, PS; Nauton, L; Sannio, F; Sevaille, L; Tanfoni, S; Verdirosa, F1
Abbasi, S; Abd El-Wahab, A; Abdallah, M; Abebe, G; Aca-Aca, G; Adama, S; Adefegha, SA; Adidigue-Ndiome, R; Adiseshaiah, P; Adrario, E; Aghajanian, C; Agnese, W; Ahmad, A; Ahmad, I; Ahmed, MFE; Akcay, OF; Akinmoladun, AC; Akutagawa, T; Alakavuklar, MA; Álava-Rabasa, S; Albaladejo-Florín, MJ; Alexandra, AJE; Alfawares, R; Alferiev, IS; Alghamdi, HS; Ali, I; Allard, B; Allen, JD; Almada, E; Alobaid, A; Alonso, GL; Alqahtani, YS; Alqarawi, W; Alsaleh, H; Alyami, BA; Amaral, BPD; Amaro, JT; Amin, SAW; Amodio, E; Amoo, ZA; Andia Biraro, I; Angiolella, L; Anheyer, D; Anlay, DZ; Annex, BH; Antonio-Aguirre, B; Apple, S; Arbuznikov, AV; Arinsoy, T; Armstrong, DK; Ash, S; Aslam, M; Asrie, F; Astur, DC; Atzrodt, J; Au, DW; Aucoin, M; Auerbach, EJ; Azarian, S; Ba, D; Bai, Z; Baisch, PRM; Balkissou, AD; Baltzopoulos, V; Banaszewski, M; Banerjee, S; Bao, Y; Baradwan, A; Barandika, JF; Barger, PM; Barion, MRL; Barrett, CD; Basudan, AM; Baur, LE; Baz-Rodríguez, SA; Beamer, P; Beaulant, A; Becker, DF; Beckers, C; Bedel, J; Bedlack, R; Bermúdez de Castro, JM; Berry, JD; Berthier, C; Bhattacharya, D; Biadgo, B; Bianco, G; Bianco, M; Bibi, S; Bigliardi, AP; Billheimer, D; Birnie, DH; Biswas, K; Blair, HC; Bognetti, P; Bolan, PJ; Bolla, JR; Bolze, A; Bonnaillie, P; Borlimi, R; Bórquez, J; Bottari, NB; Boulleys-Nana, JR; Brighetti, G; Brodeur, GM; Budnyak, T; Budnyk, S; Bukirwa, VD; Bulman, DM; Burm, R; Busman-Sahay, K; Butcher, TW; Cai, C; Cai, H; Cai, L; Cairati, M; Calvano, CD; Camacho-Ordóñez, A; Camela, E; Cameron, T; Campbell, BS; Cansian, RL; Cao, Y; Caporale, AS; Carciofi, AC; Cardozo, V; Carè, J; Carlos, AF; Carozza, R; Carroll, CJW; Carsetti, A; Carubelli, V; Casarotta, E; Casas, M; Caselli, G; Castillo-Lora, J; Cataldi, TRI; Cavalcante, ELB; Cavaleiro, A; Cayci, Z; Cebrián-Tarancón, C; Cedrone, E; Cella, D; Cereda, C; Ceretti, A; Ceroni, M; Cha, YH; Chai, X; Chang, EF; Chang, TS; Chanteux, H; Chao, M; Chaplin, BP; Chaturvedi, S; Chaturvedi, V; Chaudhary, DK; Chen, A; Chen, C; Chen, HY; Chen, J; Chen, JJ; Chen, K; Chen, L; Chen, Q; Chen, R; Chen, SY; Chen, TY; Chen, WM; Chen, X; Chen, Y; Cheng, G; Cheng, GJ; Cheng, J; Cheng, YH; Cheon, HG; Chew, KW; Chhoker, S; Chiu, WN; Choi, ES; Choi, MJ; Choi, SD; Chokshi, S; Chorny, M; Chu, KI; Chu, WJ; Church, AL; Cirrincione, A; Clamp, AR; Cleff, MB; Cohen, M; Coleman, RL; Collins, SL; Colombo, N; Conduit, N; Cong, WL; Connelly, MA; Connor, J; Cooley, K; Correa Ramos Leal, I; Cose, S; Costantino, C; Cottrell, M; Cui, L; Cundall, J; Cutaia, C; Cutler, CW; Cuypers, ML; da Silva Júnior, FMR; Dahal, RH; Damiani, E; Damtie, D; Dan-Li, W; Dang, Z; Dasa, SSK; Davin, A; Davis, DR; de Andrade, CM; de Jong, PL; de Oliveira, D; de Paula Dorigam, JC; Dean, A; Deepa, M; Delatour, C; Dell'Aiera, S; Delley, MF; den Boer, RB; Deng, L; Deng, Q; Depner, RM; Derdau, V; Derici, U; DeSantis, AJ; Desmarini, D; Diffo-Sonkoue, L; Divizia, M; Djenabou, A; Djordjevic, JT; Dobrovolskaia, MA; Domizi, R; Donati, A; Dong, Y; Dos Santos, M; Dos Santos, MP; Douglas, RG; Duarte, PF; Dullaart, RPF; Duscha, BD; Edwards, LA; Edwards, TE; Eichenwald, EC; El-Baba, TJ; Elashiry, M; Elashiry, MM; Elashry, SH; Elliott, A; Elsayed, R; Emerson, MS; Emmanuel, YO; Emory, TH; Endale-Mangamba, LM; Enten, GA; Estefanía-Fernández, K; Estes, JD; Estrada-Mena, FJ; Evans, S; Ezra, L; Faria de, RO; Farraj, AK; Favre, C; Feng, B; Feng, J; Feng, L; Feng, W; Feng, X; Feng, Z; Fernandes, CLF; Fernández-Cuadros, ME; Fernie, AR; Ferrari, D; Florindo, PR; Fong, PC; Fontes, EPB; Fontinha, D; Fornari, VJ; Fox, NP; Fu, Q; Fujitaka, Y; Fukuhara, K; Fumeaux, T; Fuqua, C; Fustinoni, S; Gabbanelli, V; Gaikwad, S; Gall, ET; Galli, A; Gancedo, MA; Gandhi, MM; Gao, D; Gao, K; Gao, M; Gao, Q; Gao, X; Gao, Y; Gaponenko, V; Garber, A; Garcia, EM; García-Campos, C; García-Donas, J; García-Pérez, AL; Gasparri, F; Ge, C; Ge, D; Ge, JB; Ge, X; George, I; George, LA; Germani, G; Ghassemi Tabrizi, S; Gibon, Y; Gillent, E; Gillies, RS; Gilmour, MI; Goble, S; Goh, JC; Goiri, F; Goldfinger, LE; Golian, M; Gómez, MA; Gonçalves, J; Góngora-García, OR; Gonul, I; González, MA; Govers, TM; Grant, PC; Gray, EH; Gray, JE; Green, MS; Greenwald, I; Gregory, MJ; Gretzke, D; Griffin-Nolan, RJ; Griffith, DC; Gruppen, EG; Guaita, A; Guan, P; Guan, X; Guerci, P; Guerrero, DT; Guo, M; Guo, P; Guo, R; Guo, X; Gupta, J; Guz, G; Hajizadeh, N; Hamada, H; Haman-Wabi, AB; Han, TT; Hannan, N; Hao, S; Harjola, VP; Harmon, M; Hartmann, MSM; Hartwig, JF; Hasani, M; Hawthorne, WJ; Haykal-Coates, N; Hazari, MS; He, DL; He, P; He, SG; Héau, C; Hebbar Kannur, K; Helvaci, O; Heuberger, DM; Hidalgo, F; Hilty, MP; Hirata, K; Hirsch, A; Hoffman, AM; Hoffmann, JF; Holloway, RW; Holmes, RK; Hong, S; Hongisto, M; Hopf, NB; Hörlein, R; Hoshino, N; Hou, Y; Hoven, NF; Hsieh, YY; Hsu, CT; Hu, CW; Hu, JH; Hu, MY; Hu, Y; Hu, Z; Huang, C; Huang, D; Huang, DQ; Huang, L; Huang, Q; Huang, R; Huang, S; Huang, SC; Huang, W; Huang, Y; Huffman, KM; Hung, CH; Hung, CT; Huurman, R; Hwang, SM; Hyun, S; Ibrahim, AM; Iddi-Faical, A; Immordino, P; Isla, MI; Jacquemond, V; Jacques, T; Jankowska, E; Jansen, JA; Jäntti, T; Jaque-Fernandez, F; Jarvis, GA; Jatt, LP; Jeon, JW; Jeong, SH; Jhunjhunwala, R; Ji, F; Jia, X; Jia, Y; Jian-Bo, Z; Jiang, GD; Jiang, L; Jiang, W; Jiang, WD; Jiang, Z; Jiménez-Hoyos, CA; Jin, S; Jobling, MG; John, CM; John, T; Johnson, CB; Jones, KI; Jones, WS; Joseph, OO; Ju, C; Judeinstein, P; Junges, A; Junnarkar, M; Jurkko, R; Kaleka, CC; Kamath, AV; Kang, X; Kantsadi, AL; Kapoor, M; Karim, Z; Kashuba, ADM; Kassa, E; Kasztura, M; Kataja, A; Katoh, T; Kaufman, JS; Kaupp, M; Kehinde, O; Kehrenberg, C; Kemper, N; Kerr, CW; Khan, AU; Khan, MF; Khan, ZUH; Khojasteh, SC; Kilburn, S; Kim, CG; Kim, DU; Kim, DY; Kim, HJ; Kim, J; Kim, OH; Kim, YH; King, C; Klein, A; Klingler, L; Knapp, AK; Ko, TK; Kodavanti, UP; Kolla, V; Kong, L; Kong, RY; Kong, X; Kore, S; Kortz, U; Korucu, B; Kovacs, A; Krahnert, I; Kraus, WE; Kuang, SY; Kuehn-Hajder, JE; Kurz, M; Kuśtrowski, P; Kwak, YD; Kyttaris, VC; Laga, SM; Laguerre, A; Laloo, A; Langaro, MC; Langham, MC; Lao, X; Larocca, MC; Lassus, J; Lattimer, TA; Lazar, S; Le, MH; Leal, DB; Leal, M; Leary, A; Ledermann, JA; Lee, JF; Lee, MV; Lee, NH; Leeds, CM; Leeds, JS; Lefrandt, JD; Leicht, AS; Leonard, M; Lev, S; Levy, K; Li, B; Li, C; Li, CM; Li, DH; Li, H; Li, J; Li, L; Li, LJ; Li, N; Li, P; Li, T; Li, X; Li, XH; Li, XQ; Li, XX; Li, Y; Li, Z; Li, ZY; Liao, YF; Lin, CC; Lin, MH; Lin, Y; Ling, Y; Links, TP; Lira-Romero, E; Liu, C; Liu, D; Liu, H; Liu, J; Liu, L; Liu, LP; Liu, M; Liu, T; Liu, W; Liu, X; Liu, XH; Liu, Y; Liuwantara, D; Ljumanovic, N; Lobo, L; Lokhande, K; Lopes, A; Lopes, RMRM; López-Gutiérrez, JC; López-Muñoz, MJ; López-Santamaría, M; Lorenzo, C; Lorusso, D; Losito, I; Lu, C; Lu, H; Lu, HZ; Lu, SH; Lu, SN; Lu, Y; Lu, ZY; Luboga, F; Luo, JJ; Luo, KL; Luo, Y; Lutomski, CA; Lv, W; M Piedade, MF; Ma, J; Ma, JQ; Ma, JX; Ma, N; Ma, P; Ma, S; Maciel, M; Madureira, M; Maganaris, C; Maginn, EJ; Mahnashi, MH; Maierhofer, M; Majetschak, M; Malla, TR; Maloney, L; Mann, DL; Mansuri, A; Marelli, E; Margulis, CJ; Marrella, A; Martin, BL; Martín-Francés, L; Martínez de Pinillos, M; Martínez-Navarro, EM; Martinez-Quintanilla Jimenez, D; Martínez-Velasco, A; Martínez-Villaseñor, L; Martinón-Torres, M; Martins, BA; Massongo, M; Mathew, AP; Mathews, D; Matsui, J; Matsumoto, KI; Mau, T; Maves, RC; Mayclin, SJ; Mayer, JM; Maynard, ND; Mayr, T; Mboowa, MG; McEvoy, MP; McIntyre, RC; McKay, JA; McPhail, MJW; McVeigh, AL; Mebazaa, A; Medici, V; Medina, DN; Mehmood, T; Mei-Li, C; Melku, M; Meloncelli, S; Mendes, GC; Mendoza-Velásquez, C; Mercadante, R; Mercado, MI; Merenda, MEZ; Meunier, J; Mi, SL; Michels, M; Mijatovic, V; Mikhailov, V; Milheiro, SA; Miller, DC; Ming, F; Mitsuishi, M; Miyashita, T; Mo, J; Mo, S; Modesto-Mata, M; Moeller, S; Monte, A; Monteiro, L; Montomoli, J; Moore, EE; Moore, HB; Moore, PK; Mor, MK; Moratalla-López, N; Moratilla Lapeña, L; Moreira, R; Moreno, MA; Mörk, AC; Morton, M; Mosier, JM; Mou, LH; Mougharbel, AS; Muccillo-Baisch, AL; Muñoz-Serrano, AJ; Mustafa, B; Nair, GM; Nakanishi, I; Nakanjako, D; Naraparaju, K; Nawani, N; Neffati, R; Neil, EC; Neilipovitz, D; Neira-Borrajo, I; Nelson, MT; Nery, PB; Nese, M; Nguyen, F; Nguyen, MH; Niazy, AA; Nicolaï, J; Nogueira, F; Norbäck, D; Novaretti, JV; O'Donnell, T; O'Dowd, A; O'Malley, DM; Oaknin, A; Ogata, K; Ohkubo, K; Ojha, M; Olaleye, MT; Olawande, B; Olomo, EJ; Ong, EWY; Ono, A; Onwumere, J; Ortiz Bibriesca, DM; Ou, X; Oza, AM; Ozturk, K; Özütemiz, C; Palacio-Pastrana, C; Palaparthi, A; Palevsky, PM; Pan, K; Pantanetti, S; Papachristou, DJ; Pariani, A; Parikh, CR; Parissis, J; Paroul, N; Parry, S; Patel, N; Patel, SM; Patel, VC; Pawar, S; Pefura-Yone, EW; Peixoto Andrade, BCO; Pelepenko, LE; Peña-Lora, D; Peng, S; Pérez-Moro, OS; Perez-Ortiz, AC; Perry, LM; Peter, CM; Phillips, NJ; Phillips, P; Pia Tek, J; Piner, LW; Pinto, EA; Pinto, SN; Piyachaturawat, P; Poka-Mayap, V; Polledri, E; Poloni, TE; Ponessa, G; Poole, ST; Post, AK; Potter, TM; Pressly, BB; Prouty, MG; Prudêncio, M; Pulkki, K; Pupier, C; Qian, H; Qian, ZP; Qiu, Y; Qu, G; Rahimi, S; Rahman, AU; Ramadan, H; Ramanna, S; Ramirez, I; Randolph, GJ; Rasheed, A; Rault, J; Raviprakash, V; Reale, E; Redpath, C; Rema, V; Remucal, CK; Remy, D; Ren, T; Ribeiro, LB; Riboli, G; Richards, J; Rieger, V; Rieusset, J; Riva, A; Rivabella Maknis, T; Robbins, JL; Robinson, CV; Roche-Campo, F; Rodriguez, R; Rodríguez-de-Cía, J; Rollenhagen, JE; Rosen, EP; Rub, D; Rubin, N; Rubin, NT; Ruurda, JP; Saad, O; Sabell, T; Saber, SE; Sabet, M; Sadek, MM; Saejio, A; Salinas, RM; Saliu, IO; Sande, D; Sang, D; Sangenito, LS; Santos, ALSD; Sarmiento Caldas, MC; Sassaroli, S; Sassi, V; Sato, J; Sauaia, A; Saunders, K; Saunders, PR; Savarino, SJ; Scambia, G; Scanlon, N; Schetinger, MR; Schinkel, AFL; Schladweiler, MC; Schofield, CJ; Schuepbach, RA; Schulz, J; Schwartz, N; Scorcella, C; Seeley, J; Seemann, F; Seinige, D; Sengoku, T; Seravalli, J; Sgromo, B; Shaheen, MY; Shan, L; Shanmugam, S; Shao, H; Sharma, S; Shaw, KJ; Shen, BQ; Shen, CH; Shen, P; Shen, S; Shen, Y; Shen, Z; Shi, J; Shi-Li, L; Shimoda, K; Shoji, Y; Shun, C; Silva, MA; Silva-Cardoso, J; Simas, NK; Simirgiotis, MJ; Sincock, SA; Singh, MP; Sionis, A; Siu, J; Sivieri, EM; Sjerps, MJ; Skoczen, SL; Slabon, A; Slette, IJ; Smith, MD; Smith, S; Smith, TG; Snapp, KS; Snow, SJ; Soares, MCF; Soberman, D; Solares, MD; Soliman, I; Song, J; Sorooshian, A; Sorrell, TC; Spinar, J; Staudt, A; Steinhart, C; Stern, ST; Stevens, DM; Stiers, KM; Stimming, U; Su, YG; Subbian, V; Suga, H; Sukhija-Cohen, A; Suksamrarn, A; Suksen, K; Sun, J; Sun, M; Sun, P; Sun, W; Sun, XF; Sun, Y; Sundell, J; Susan, LF; Sutjarit, N; Swamy, KV; Swisher, EM; Sykes, C; Takahashi, JA; Talmor, DS; Tan, B; Tan, ZK; Tang, L; Tang, S; Tanner, JJ; Tanwar, M; Tarazi, Z; Tarvasmäki, T; Tay, FR; Teketel, A; Temitayo, GI; Thersleff, T; Thiessen Philbrook, H; Thompson, LC; Thongon, N; Tian, B; Tian, F; Tian, Q; Timothy, AT; Tingle, MD; Titze, IR; Tolppanen, H; Tong, W; Toyoda, H; Tronconi, L; Tseng, CH; Tu, H; Tu, YJ; Tung, SY; Turpault, S; Tuynman, JB; Uemoto, AT; Ugurlu, M; Ullah, S; Underwood, RS; Ungell, AL; Usandizaga-Elio, I; Vakonakis, I; van Boxel, GI; van den Beucken, JJJP; van der Boom, T; van Slegtenhorst, MA; Vanni, JR; Vaquera, A; Vasconcellos, RS; Velayos, M; Vena, R; Ventura, G; Verso, MG; Vincent, RP; Vitale, F; Vitali, S; Vlek, SL; Vleugels, MPH; Volkmann, N; Vukelic, M; Wagner Mackenzie, B; Wairagala, P; Waller, SB; Wan, J; Wan, MT; Wan, Y; Wang, CC; Wang, H; Wang, J; Wang, JF; Wang, K; Wang, L; Wang, M; Wang, S; Wang, WM; Wang, X; Wang, Y; Wang, YD; Wang, YF; Wang, Z; Wang, ZG; Warriner, K; Weberpals, JI; Weerachayaphorn, J; Wehrli, FW; Wei, J; Wei, KL; Weinheimer, CJ; Weisbord, SD; Wen, S; Wendel Garcia, PD; Williams, JW; Williams, R; Winkler, C; Wirman, AP; Wong, S; Woods, CM; Wu, B; Wu, C; Wu, F; Wu, P; Wu, S; Wu, Y; Wu, YN; Wu, ZH; Wurtzel, JGT; Xia, L; Xia, Z; Xia, ZZ; Xiao, H; Xie, C; Xin, ZM; Xing, Y; Xing, Z; Xu, S; Xu, SB; Xu, T; Xu, X; Xu, Y; Xue, L; Xun, J; Yaffe, MB; Yalew, A; Yamamoto, S; Yan, D; Yan, H; Yan, S; Yan, X; Yang, AD; Yang, E; Yang, H; Yang, J; Yang, JL; Yang, K; Yang, M; Yang, P; Yang, Q; Yang, S; Yang, W; Yang, X; Yang, Y; Yao, JC; Yao, WL; Yao, Y; Yaqub, TB; Ye, J; Ye, W; Yen, CW; Yeter, HH; Yin, C; Yip, V; Yong-Yi, J; Yu, HJ; Yu, MF; Yu, S; Yu, W; Yu, WW; Yu, X; Yuan, P; Yuan, Q; Yue, XY; Zaia, AA; Zakhary, SY; Zalwango, F; Zamalloa, A; Zamparo, P; Zampini, IC; Zani, JL; Zeitoun, R; Zeng, N; Zenteno, JC; Zepeda-Palacio, C; Zhai, C; Zhang, B; Zhang, G; Zhang, J; Zhang, K; Zhang, Q; Zhang, R; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, B; Zhao, D; Zhao, G; Zhao, H; Zhao, Q; Zhao, R; Zhao, S; Zhao, T; Zhao, X; Zhao, XA; Zhao, Y; Zhao, Z; Zheng, Z; Zhi-Min, G; Zhou, CL; Zhou, HD; Zhou, J; Zhou, W; Zhou, XQ; Zhou, Z; Zhu, C; Zhu, H; Zhu, L; Zhu, Y; Zitzmann, N; Zou, L; Zou, Y1
Maquieira, Á; Morais, S; Peña-Mendizabal, E1
Kois, AK; Kuti, JL; Nicolau, DP1
Bassetti, M; Battaglini, D; Giacobbe, DR; Pelosi, P; Vena, A1
Bassetti, M; Giacobbe, DR; Pelosi, P; Robba, C; Vena, A1
Chen, L; Jiang, J; Li, X; Li, Y; Liang, X; Tang, X1
Gasparetto, J; Telles, JP; Tuon, FF; Zequinão, T1
Abdelraouf, K; Nicolau, DP; Reyes, S1
Abbaszadeh, F; Baradaran, B; Dehghani, L; Hasani, A; Rezaee, MA; Samadi Kafil, H; Vahhabi, A1
Bagheri, H; Dao, VT; Montastruc, JL; Nguyen, HA; Nguyen, KD; Vu, DH1
Arthur, M; Braud, E; Edoo, Z; Etheve-Quelquejeu, M; Fonvielle, M; Iannazzo, L; Riomet, M; Rusconi, F; Saidjalolov, S; Sallustrau, A; Taran, F1
Bonnin, RA; Dortet, L; Emeraud, C; Gonzalez, C; Iorga, BI; Naas, T; Oueslati, S; Rima, M1
Cho, HS; D'Souza, R; Kim, H; Lee, H; Nguyen, LP; Pinto, NA; Vu, TN; Yong, D1
Bhagwat, S; Joshi, P; Patel, M; Shrivastava, R1
Aoki, T; Komano, K; Kusano, H; Matsumoto, S; Oguma, T; Sato, J; Sato, T; Shibuya, S; Yamawaki, K; Yasuo, K; Yokoo, K1
Armstrong, T; Fenn, SJ; Hardie, KR1
Johns, ML; Klimko, CV; Sanders, JM1
Alquethamy, SF; Bauer, MJ; Beatson, SA; Blaskovich, MAT; Brouwer, S; Cork, AJ; De Oliveira, DMP; El-Deeb, IM; Forde, BM; Harbison-Price, N; Keller, N; Li, G; McDevitt, CA; McEwan, AG; Paterson, DL; Phan, MD; Roberts, JA; Schembri, MA; Steiner, B; von Itzstein, M; Walker, MJ; Zhang, B; Zuegg, J1
Aoki, T; Komano, K; Kusano, H; Matsumoto, S; Nakamura, R; Oguma, T; Sato, J; Sato, T; Shibuya, S; Yamawaki, K; Yokoo, K1
Albur, M; Attwood, M; Bowker, KE; MacGowan, AP; Noel, AR1
Blaskovich, M1
Abaza, M; Aboubakr, M; Awad, D; Edris, S; Fouad, M; Hamad, A; Hussein, A; Nabil, M; Ramadan, H; Sabeq, I; Shama, S1
Anes, E; Catalão, MJ; Gomes, JP; Macedo, R; Miragaia, M; Nunes, A; Olivença, F; Pires, D; Silveiro, C1
Beer, M; Chudyk, EI; Jones, CA; Limb, MAL; Mulholland, AJ; Spencer, J; van der Kamp, MW1
Ju, F; Zhang, G; Zhang, Z1
Barata, RR; Brasiliense, DM; Camargo, DS; Carneiro, ICRS; Costa, CJS; Dutra, LMG; Lobato, A; Martins, WMBS; Souza, CO1
Alfandari, S; Bajolet, O; Blanchard, H; Colomb-Cotinat, M; Daniau, C; Dumartin, C; Lecuru, M; Simon, L1
Dartois, V; Dick, T; Negatu, DA; Zimmerman, MD1
Chen, DQ; Chen, EZ; Ling, JH; Liu, WT; Peng, C; Wang, LJ; Yang, L; Yuan, PB; Zhong, YX; Zhu, JH1
Buranapraditkun, S; Chongpison, Y; Klaewsongkram, J; Mongkolpathumrat, P; Palapinyo, S; Thantiworasit, P1
Gehlot, P; P, H1
Cabañero-Navalón, MD; Garcia-Bustos, V; Salavert Lletí, M1
Axelrod, P; Holaday, E; Mishkin, A; Motzer, AR1
Arimuthu, DA; Mazlan, SA; Shahar, S1
Cai, Y; Wang, J; Wang, Y; Xiao, Q; Xu, J; Zhang, H; Zhu, M1
Gatti, M; Pea, F1
Chen, L; He, XP; Hong, SJ; Hua, J; Jing, RC; Luo, XY; Xue, HW; Yuan, CY; Yue, Y1
Ambrose, PG; Bhavnani, SM; Conde, H; Cotroneo, N; Friedrich, LV; Jones, S; VanScoy, BD1
Crow, A; Dai, Y; Dowson, CG; Geisinger, E; Isberg, RR; Lloyd, AJ; Micelli, C; Raustad, N; Roper, DI1
Bonomo, RA; Calvopiña, K; Dmitrienko, GI; Hinchliffe, P; Mojica, MF; Rabe, P; Schofield, CJ; Spencer, J; Vila, AJ1
Chang, YH; Hsu, CK; Huang, PY; Lai, CC; Liu, TH; Tang, HJ; Tsai, YW; Wu, JY1
Duru, C; Ebruke, BE; Egah, R; Hanga, F; James, AO; Jibir, B; Medugu, N; Obaro, SK; Odili, V; Olanipekun, G; Olateju, EK; Tenover, FC; Tickler, IA1
Allel, K; Araos, R; Arias, CA; Conejeros, J; García, P; Lessa, FC; Martínez, JRW; McGovern, O; Munita, JM; Orellana Chea, C; Patel, TS; Peters, A; Riquelme-Neira, R; Rivas, L; Rojas, P; Spencer-Sandino, M; Undurraga, EA1
Caseris, M; Cohen, R; Dortet, L; Lorrot, M; Raymond, J; Toubiana, J1

Reviews

56 review(s) available for carbapenems and beta-lactams

ArticleYear
Bacterial production of carbapenems and clavams: evolution of beta-lactam antibiotic pathways.
    Trends in microbiology, 1998, Volume: 6, Issue:5

    Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Clavulanic Acids

1998
Ertapenem: a new carbapenem.
    Expert opinion on investigational drugs, 2001, Volume: 10, Issue:6

    Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Clinical Trials, Phase II as Topic; Drug Evaluation; Ertapenem; Gram-Negative Aerobic Bacteria; Gram-Positive Bacteria; Humans; Lactams; Microbial Sensitivity Tests

2001
Properties and potential of ertapenem.
    The Journal of antimicrobial chemotherapy, 2003, Volume: 52, Issue:3

    Topics: Bacteria; Bacterial Infections; beta-Lactams; Carbapenems; Clinical Trials as Topic; Drug Resistance, Bacterial; Ertapenem; Half-Life; Humans; Lactams

2003
Ertapenem, the first of a new group of carbapenems.
    The Journal of antimicrobial chemotherapy, 2003, Volume: 52, Issue:4

    Topics: Animals; beta-Lactams; Carbapenems; Clinical Trials as Topic; Cross Infection; Ertapenem; Humans; Lactams

2003
Ertapenem: a Group 1 carbapenem with distinct antibacterial and pharmacological properties.
    The Journal of antimicrobial chemotherapy, 2004, Volume: 53 Suppl 2

    Topics: Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; beta-Lactams; Carbapenems; Community-Acquired Infections; Ertapenem; Humans; Lactams

2004
Appropriate use of the carbapenems.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2004, Volume: 94, Issue:10 Pt 2

    Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbapenems; Cilastatin; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Drug Utilization; Ertapenem; Humans; Imipenem; Lactams; Meropenem; Patient Selection; Pneumonia, Bacterial; Practice Patterns, Physicians'; Protease Inhibitors; South Africa; Surgical Wound Infection; Thienamycins; Urinary Tract Infections

2004
[Development of new synthetic method using organometallic complexes and an application toward natural product synthesis].
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2005, Volume: 125, Issue:1

    Topics: Acetylene; Alkaloids; Benzodiazepinones; beta-Lactams; Carbapenems; Carbon Dioxide; Carbon Monoxide; Catalysis; Chemistry, Organic; Cyclization; Ethylenes; Gases; Harringtonines; Homoharringtonine; Indole Alkaloids; Indoles; Nitrogen; Organometallic Compounds; Quinolines; Quinolizines; Strychnine

2005
Ertapenem: review of a new carbapenem.
    Expert review of anti-infective therapy, 2005, Volume: 3, Issue:1

    Topics: Animals; beta-Lactams; Carbapenems; Drugs, Investigational; Ertapenem; Humans; Lactams

2005
Redefining penems.
    Biochemical pharmacology, 2006, Mar-30, Volume: 71, Issue:7

    Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Structure; Penicillins

2006
Extended-spectrum beta-lactamases in Taiwan: epidemiology, detection, treatment and infection control.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2006, Volume: 39, Issue:4

    Topics: beta-Lactamases; beta-Lactams; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Molecular Epidemiology; Taiwan

2006
[Structure-activity relationships of penicillin G to tricyclic beta-lactams].
    Pharmazie in unserer Zeit, 2006, Volume: 35, Issue:5

    Topics: Bacteria; beta-Lactams; Carbapenems; Cephalosporins; Humans; Penicillin G; Penicillins; Structure-Activity Relationship

2006
[Opposition to Ehrlich's paradigm of selective toxicity. Adverse effects of beta lactam antibiotics].
    Pharmazie in unserer Zeit, 2006, Volume: 35, Issue:5

    Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cephalosporins; Diarrhea; Drug Hypersensitivity; Enterocolitis, Pseudomembranous; Humans; Monobactams; Penicillins

2006
Part II. Introduction to the beta-lactam antibiotics.
    The Journal of the Oklahoma State Medical Association, 2006, Volume: 99, Issue:10

    Topics: Administration, Oral; Anaphylaxis; Anti-Bacterial Agents; Bacteria; beta-Lactam Resistance; beta-Lactams; Carbapenems; Cephalosporins; Cross Reactions; Desensitization, Immunologic; Drug Hypersensitivity; Humans; Injections, Intravenous; Microbial Sensitivity Tests; Monobactams; Penicillins; Skin Tests; Time Factors

2006
Carbapenems for the treatment of immunocompetent adult patients with nosocomial pneumonia.
    The European respiratory journal, 2007, Volume: 29, Issue:3

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aminoglycosides; beta-Lactams; Carbapenems; Cross Infection; Drug Resistance, Multiple; Drug Therapy, Combination; Fluoroquinolones; Humans; Immunocompetence; Intensive Care Units; Meropenem; Pneumonia, Bacterial; Pseudomonas Infections; Randomized Controlled Trials as Topic; Respiration, Artificial; Survival Rate; Thienamycins; Treatment Outcome

2007
Part V. Other beta-lactam antimicrobials.
    The Journal of the Oklahoma State Medical Association, 2007, Volume: 100, Issue:1

    Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbapenems; Humans; Monobactams

2007
Comparative review of the carbapenems.
    Drugs, 2007, Volume: 67, Issue:7

    Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbapenems; Doripenem; Ertapenem; Humans; Imipenem; Meropenem; Thienamycins

2007
Carbapenems in the USA: focus on doripenem.
    Expert review of anti-infective therapy, 2007, Volume: 5, Issue:5

    Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbapenems; Clinical Trials as Topic; Doripenem; Drug Resistance, Multiple, Bacterial; Ertapenem; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Structure-Activity Relationship; Thienamycins; United States

2007
[Attention-getting cross infections: Extended-spectrum beta-lactamase-producing bacterial infections].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2007, Nov-10, Volume: 96, Issue:11

    Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Proteus; Proteus Infections

2007
Carbapenems: a potent class of antibiotics.
    Expert opinion on pharmacotherapy, 2008, Volume: 9, Issue:1

    Topics: Anti-Bacterial Agents; Bacteria; beta-Lactams; Carbapenems; Clinical Trials as Topic; Doripenem; Ertapenem; Humans; Imipenem; Meropenem; Molecular Structure; Structure-Activity Relationship; Thienamycins

2008
Defining an extended-spectrum beta-lactamase.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2008, Volume: 14 Suppl 1

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Escherichia coli; Gram-Negative Bacteria; Kinetics; Microbial Sensitivity Tests; Mutation

2008
Parenteral carbapenems.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2008, Volume: 14 Suppl 1

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Ertapenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Humans; Imipenem; Infusions, Parenteral; Meropenem; Thienamycins

2008
The role of carbapenems in the treatment of severe nosocomial respiratory tract infections.
    Expert opinion on pharmacotherapy, 2008, Volume: 9, Issue:4

    Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cross Infection; Doripenem; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Ertapenem; Humans; Imipenem; Meropenem; Patient Selection; Pneumonia, Bacterial; Respiratory Tract Infections; Severity of Illness Index; Thienamycins; Treatment Outcome

2008
[Broad-spectrum beta-lactamases in Gram-negative bacteria].
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2008, Dec-04, Volume: 128, Issue:23

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Monobactams; Penicillins; Plasmids

2008
Extended-spectrum beta-lactamases: implications for the clinical laboratory and therapy.
    The Korean journal of laboratory medicine, 2008, Volume: 28, Issue:6

    Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Disk Diffusion Antimicrobial Tests; Enterobacteriaceae; Enterobacteriaceae Infections; Fluoroquinolones; Humans; Microbial Sensitivity Tests

2008
Addressing the challenge of extended-spectrum beta-lactamases.
    Current opinion in investigational drugs (London, England : 2000), 2009, Volume: 10, Issue:2

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Randomized Controlled Trials as Topic; Risk Factors; Treatment Outcome; Urinary Tract Infections

2009
[Update on antimicrobial chemotherapy].
    Medecine et maladies infectieuses, 2010, Volume: 40, Issue:3

    Topics: Acetamides; Aminoglycosides; Anti-Infective Agents; beta-Lactams; Carbapenems; Cephalosporins; Daptomycin; Doripenem; Drug Resistance, Bacterial; Ertapenem; Fluoroquinolones; France; Humans; Linezolid; Lipoglycopeptides; Minocycline; Oxazolidinones; Penicillins; Pyrimidines; Teicoplanin; Tigecycline

2010
The complex clinical picture of beta-lactam hypersensitivity: penicillins, cephalosporins, monobactams, carbapenems, and clavams.
    The Medical clinics of North America, 2010, Volume: 94, Issue:4

    Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cephalosporins; Clavulanic Acids; Cross Reactions; Drug Hypersensitivity; Humans; Monobactams; Penicillins; Risk Factors; Skin Tests

2010
The future of the β-lactams.
    Current opinion in microbiology, 2010, Volume: 13, Issue:5

    Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Monobactams

2010
Carbapenems: past, present, and future.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:11

    Topics: Anti-Bacterial Agents; beta-Alanine; beta-Lactams; Carbapenems; Cilastatin; Cilastatin, Imipenem Drug Combination; Doripenem; Drug Combinations; Ertapenem; Humans; Imipenem; Thienamycins

2011
Carbapenem stewardship: does ertapenem affect Pseudomonas susceptibility to other carbapenems? A review of the evidence.
    International journal of antimicrobial agents, 2012, Volume: 39, Issue:1

    Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Clinical Trials as Topic; Drug Interactions; Drug Resistance, Bacterial; Ertapenem; Humans; Microbial Sensitivity Tests; Pseudomonas; Pseudomonas aeruginosa; Pseudomonas Infections

2012
Colistin: new lessons on an old antibiotic.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2012, Volume: 18, Issue:1

    Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Clinical Trials as Topic; Colistin; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans

2012
Pharmacokinetics of beta-lactam antibiotics in patients with intra-abdominal disease: a structured review.
    Surgical infections, 2012, Volume: 13, Issue:1

    Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cephalosporins; Diffusion; Drainage; Humans; Intraabdominal Infections; Metabolic Clearance Rate; Penicillins

2012
Ertapenem use and antimicrobial resistance to group 2 carbapenems in Gram-negative infections: a systematic review.
    Expert review of anti-infective therapy, 2013, Volume: 11, Issue:1

    Topics: Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Carbapenems; Ertapenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Pseudomonas aeruginosa

2013
Impact of antimicrobial multidrug resistance on inpatient care cost: an evaluation of the evidence.
    Expert review of anti-infective therapy, 2013, Volume: 11, Issue:3

    Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Gram-Negative Bacteria; Hospital Costs; Humans; Methicillin-Resistant Staphylococcus aureus

2013
The risk of seizures among the carbapenems: a meta-analysis.
    The Journal of antimicrobial chemotherapy, 2014, Volume: 69, Issue:8

    Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Child; Cilastatin; Cilastatin, Imipenem Drug Combination; Doripenem; Drug Combinations; Ertapenem; Humans; Imipenem; Meropenem; Risk; Seizures; Thienamycins

2014
Penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus.
    IUBMB life, 2014, Volume: 66, Issue:8

    Topics: Allosteric Regulation; beta-Lactams; Carbapenems; Cell Wall; Cephalosporins; Cross-Linking Reagents; Drug Resistance, Bacterial; Methicillin-Resistant Staphylococcus aureus; Models, Molecular; Molecular Structure; Penicillin-Binding Proteins; Penicillins; Peptide Synthases

2014
Mechanisms of β-lactam killing and resistance in the context of Mycobacterium tuberculosis.
    The Journal of antibiotics, 2014, Volume: 67, Issue:9

    Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Clavulanic Acid; Drug Therapy, Combination; Humans; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant

2014
Emerging issues in gram-negative bacterial resistance: an update for the practicing clinician.
    Mayo Clinic proceedings, 2015, Volume: 90, Issue:3

    Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Drug Resistance, Bacterial; Global Health; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Incidence; Infection Control

2015
Carbapenems to Treat Multidrug and Extensively Drug-Resistant Tuberculosis: A Systematic Review.
    International journal of molecular sciences, 2016, Mar-12, Volume: 17, Issue:3

    Topics: Antitubercular Agents; beta-Lactams; Carbapenems; Clinical Studies as Topic; Ertapenem; Extensively Drug-Resistant Tuberculosis; Humans; Imipenem; Meropenem; Thienamycins; Treatment Outcome; Tuberculosis, Multidrug-Resistant

2016
Carbapenems vs. alternative β-lactams for the treatment of nosocomial pneumonia: A systematic review and meta-analysis.
    International journal of antimicrobial agents, 2018, Volume: 52, Issue:4

    Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbapenems; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Healthcare-Associated Pneumonia; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Odds Ratio; Pseudomonas aeruginosa; Randomized Controlled Trials as Topic; Risk Factors; Staphylococcus aureus; Survival Analysis; Treatment Outcome

2018
Roles of 2-oxoglutarate oxygenases and isopenicillin N synthase in β-lactam biosynthesis.
    Natural product reports, 2018, 08-15, Volume: 35, Issue:8

    Topics: beta-Lactams; Carbapenems; Cephalosporins; Ketoglutaric Acids; Mixed Function Oxygenases; Oxidoreductases; Oxygenases

2018
Novel β-lactam-β-lactamase inhibitor combinations: expectations for the treatment of carbapenem-resistant Gram-negative pathogens.
    Expert opinion on drug metabolism & toxicology, 2019, Volume: 15, Issue:2

    Topics: Animals; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Carbapenems; Drug Combinations; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans

2019
β-Lactamases and β-Lactamase Inhibitors in the 21st Century.
    Journal of molecular biology, 2019, 08-23, Volume: 431, Issue:18

    Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Catalytic Domain; Drug Combinations; Drug Resistance, Bacterial; Enterobacteriaceae; Gram-Negative Bacteria; Humans; Interspersed Repetitive Sequences

2019
    Zeitschrift fur Gesundheitswissenschaften = Journal of public health, 2022, Volume: 30, Issue:2

    Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea

2022
Unresolved issues in the identification and treatment of carbapenem-resistant Gram-negative organisms.
    Current opinion in infectious diseases, 2020, Volume: 33, Issue:6

    Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Genotyping Techniques; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa

2020
The role of new antimicrobials for Gram-negative infections in daily clinical practice.
    Current opinion in infectious diseases, 2020, Volume: 33, Issue:6

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azabicyclo Compounds; beta-Lactams; Carbapenems; Cefiderocol; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans; Imipenem; Microbial Sensitivity Tests; Polymyxins; Sisomicin; Tazobactam; Tetracyclines

2020
Treatment of extended-spectrum β-lactamases infections: what is the current role of new β-lactams/β-lactamase inhibitors?
    Current opinion in infectious diseases, 2020, Volume: 33, Issue:6

    Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Ceftaroline; Ceftazidime; Cephalosporins; Cyclooctanes; Drug Combinations; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Piperacillin, Tazobactam Drug Combination; Public Health; Sepsis; Tazobactam

2020
Carbapenems versus alternative β-lactams monotherapy or in combination for febrile neutropenia: Systematic review and meta-analysis of randomized controlled trial.
    Medicine, 2020, Oct-23, Volume: 99, Issue:43

    Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Drug Therapy, Combination; Febrile Neutropenia; Humans; Randomized Controlled Trials as Topic

2020
Carbapenem stewardship with ertapenem and antimicrobial resistance-a scoping review.
    Revista da Sociedade Brasileira de Medicina Tropical, 2020, Volume: 53

    Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Drug Resistance, Bacterial; Ertapenem; Microbial Sensitivity Tests

2020
A plethora of carbapenem resistance in
    Journal of chemotherapy (Florence, Italy), 2021, Volume: 33, Issue:3

    Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacteriophages; beta-Lactamases; beta-Lactams; Carbapenems; Cefiderocol; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Polymyxin B; Tetracyclines

2021
JMM Profile: Carbapenems: a broad-spectrum antibiotic.
    Journal of medical microbiology, 2021, Volume: 70, Issue:12

    Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Meropenem

2021
Resistance to beta-lactams in Gram-negative bacilli: relevance and potential therapeutic alternatives.
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2022, Volume: 35 Suppl 2

    Topics: Animals; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Carbapenems; Cattle; Cephalosporins; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Microbial Sensitivity Tests; Quinolones; Tetracyclines

2022
Carbapenem-sparing beta-lactam/beta-lactamase inhibitors versus carbapenems for bloodstream infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae: a systematic review and meta-analysis.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2023, Volume: 128

    Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Lactams; Randomized Controlled Trials as Topic; Sepsis

2023
Jumping into the future: overcoming pharmacokinetic/pharmacodynamic hurdles to optimize the treatment of severe difficult to treat-Gram-negative infections with novel beta-lactams.
    Expert review of anti-infective therapy, 2023, Volume: 21, Issue:2

    Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests

2023
Clinical efficacy of ertapenem vs. other carbapenems for the treatment of extended-spectrum-β-lactamase-producing Enterobacterales infection: A systematic review and meta-analysis.
    Journal of global antimicrobial resistance, 2023, Volume: 33

    Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Ertapenem; Gammaproteobacteria; Humans; Treatment Outcome

2023
Treatment of Resistant Gram-negative bacilli in children.
    Infectious diseases now, 2023, Volume: 53, Issue:8S

    Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Child; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans

2023

Trials

5 trial(s) available for carbapenems and beta-lactams

ArticleYear
Comparative disposition of [14C]ertapenem, a novel carbapenem antibiotic, in rat, monkey and man.
    Xenobiotica; the fate of foreign compounds in biological systems, 2004, Volume: 34, Issue:4

    Topics: Adult; Animals; beta-Lactams; Carbapenems; Carbon Radioisotopes; Ertapenem; Feces; Female; Humans; Lactams; Macaca mulatta; Male; Metabolic Clearance Rate; Middle Aged; Organ Specificity; Radioisotope Dilution Technique; Radiopharmaceuticals; Rats; Species Specificity; Tissue Distribution

2004
Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: a multinational pre-registered cohort study.
    The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:6

    Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Female; Humans; Male; Middle Aged; Retrospective Studies; Sepsis; Survival Analysis; Treatment Outcome

2016
Efficacy and safety of de-escalation therapy to ertapenem for treatment of infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae: an open-label randomized controlled trial.
    BMC infectious diseases, 2017, 03-01, Volume: 17, Issue:1

    Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Female; Humans; Male; Middle Aged; Treatment Outcome; Urinary Tract Infections

2017
Double carbapenem as a rescue strategy for the treatment of severe carbapenemase-producing Klebsiella pneumoniae infections: a two-center, matched case-control study.
    Critical care (London, England), 2017, 07-05, Volume: 21, Issue:1

    Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Case-Control Studies; Drug Resistance, Multiple; Ertapenem; Female; Humans; Italy; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Statistics, Nonparametric

2017
    Zeitschrift fur Gesundheitswissenschaften = Journal of public health, 2022, Volume: 30, Issue:2

    Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea

2022

Other Studies

272 other study(ies) available for carbapenems and beta-lactams

ArticleYear
Decreases of the susceptibility to low molecular weight beta-lactam antibiotics in imipenem-resistant Pseudomonas aeruginosa mutants: role of outer membrane protein D2 in their diffusion.
    The Journal of antimicrobial chemotherapy, 1990, Volume: 25, Issue:2

    Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; beta-Lactams; Carbapenems; Diffusion; Drug Resistance, Microbial; Electrophoresis, Polyacrylamide Gel; Imipenem; Lactams; Liposomes; Microbial Sensitivity Tests; Molecular Weight; Permeability; Pseudomonas aeruginosa; Thienamycins

1990
In-vitro activity of a new penem FCE 22101.
    The Journal of antimicrobial chemotherapy, 1989, Volume: 23 Suppl C

    Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactamases; beta-Lactams; Carbapenems; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests

1989
Interactions of FCE 22101 with class I beta-lactamases.
    The Journal of antimicrobial chemotherapy, 1989, Volume: 23 Suppl C

    Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamases; beta-Lactams; Carbapenems; Culture Media; Enzyme Induction; Microbial Sensitivity Tests; Mutation

1989
In-vitro activity of FCE 22101 and synergy studies with other antimicrobial agents.
    The Journal of antimicrobial chemotherapy, 1989, Volume: 23 Suppl C

    Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Ciprofloxacin; Drug Resistance, Microbial; Drug Synergism; Gentamicins; Gram-Positive Bacteria; Microbial Sensitivity Tests

1989
Novel carbapenem derivative SF2103A: studies on the mode of beta-lactamase inactivation.
    Antimicrobial agents and chemotherapy, 1984, Volume: 25, Issue:3

    Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Binding, Competitive; Carbapenems; Chromatography, Gel; Citrobacter; Enzyme Activation; Escherichia coli; Kinetics; Proteus vulgaris

1984
Comparison of in vitro activity of FCE 22101, a new penem, with those of other beta-lactam antibiotics.
    Antimicrobial agents and chemotherapy, 1983, Volume: 24, Issue:6

    Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamases; beta-Lactams; Carbapenems; Microbial Sensitivity Tests

1983
A novel beta-lactamase inhibitor, SF-2103 A produced by a Streptomyces.
    The Journal of antibiotics, 1982, Volume: 35, Issue:4

    Topics: beta-Lactamase Inhibitors; beta-Lactams; Carbapenems; Chemical Phenomena; Chemistry; Streptomyces

1982
Urinary bladder hyperplasia in the rat: non-specific pathogenetic considerations using a beta-lactam antibiotic.
    Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie, 1994, Volume: 46, Issue:4-5

    Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Hydrogen-Ion Concentration; Hyperplasia; Kidney; Lactams; Male; Precancerous Conditions; Rats; Time Factors; Urinary Bladder; Urinary Bladder Diseases; Urinary Bladder Neoplasms; Urine

1994
Role of cephalosporinase in carbapenem resistance of clinical isolates of Pseudomonas aeruginosa.
    Antimicrobial agents and chemotherapy, 1993, Volume: 37, Issue:6

    Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Carbapenems; Cephalosporinase; Drug Resistance, Microbial; Humans; Hydrolysis; Imipenem; Lactams; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Thienamycins

1993
Antibacterial activity of T-5575, a novel 2-carboxypenam, and its stability to beta-lactamase.
    The Journal of antimicrobial chemotherapy, 1997, Volume: 39, Issue:1

    Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Gram-Negative Bacteria; Hydrolysis; Imipenem; Kinetics; Mutation

1997
In-vitro activity of 21 beta-lactam antibiotics against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
    The Journal of antimicrobial chemotherapy, 1998, Volume: 41, Issue:3

    Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cefaclor; Cefadroxil; Cefatrizine; Cefepime; Cefixime; Cefotaxime; Cefpirome; Cefpodoxime; Ceftazidime; Ceftibuten; Ceftizoxime; Ceftriaxone; Cefuroxime; Cephalosporins; Cephradine; Drug Resistance, Microbial; Drug Resistance, Multiple; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin; Pneumococcal Infections; Serotyping; Species Specificity; Streptococcus pneumoniae

1998
Interactions of beta-lactamases with sanfetrinem (GV 104326) compared to those with imipenem and with oral beta-lactams.
    Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:5

    Topics: Anti-Bacterial Agents; Bacteria; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Drug Interactions; Drug Resistance, Microbial; Enzyme Induction; Hydrolysis; Imipenem; Klebsiella; Lactams; Microbial Sensitivity Tests

1998
Evaluation of the in vitro activity of six broad-spectrum beta-lactam antimicrobial agents tested against over 2,000 clinical isolates from 22 medical centers in Japan. Japan Antimicrobial Resistance Study Group.
    Diagnostic microbiology and infectious disease, 1999, Volume: 34, Issue:2

    Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactam Resistance; beta-Lactams; Carbapenems; Enterobacteriaceae; Evaluation Studies as Topic; Gram-Negative Bacteria; Humans; Japan; Microbial Sensitivity Tests; Quality Control; Staphylococcus

1999
In vitro antibacterial activity of LJC 11,036, an active metabolite of L-084, a new oral carbapenem antibiotic with potent antipneumococcal activity.
    Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:8

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Carrier Proteins; Cefdinir; Cephalosporins; Dipeptidases; Drug Stability; Escherichia coli Proteins; Hexosyltransferases; Imipenem; Lactams; Levofloxacin; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Ofloxacin; Penicillin-Binding Proteins; Peptidoglycan Glycosyltransferase; Peptidyl Transferases; Protein Binding; Serine-Type D-Ala-D-Ala Carboxypeptidase; Thienamycins

1999
Synthesis and anti-Helicobacter pylori activity of FR182024, a new cephem derivative.
    Bioorganic & medicinal chemistry letters, 1999, Nov-01, Volume: 9, Issue:21

    Topics: Amoxicillin; Animals; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Clarithromycin; Disease Models, Animal; Helicobacter pylori; Lactams; Mice; Molecular Structure

1999
In vitro activity of DU-6681a, an active form of the new oral carbapenem compound DZ-2640, in comparison with that of R-95867, faropenem and oral cephalosporins.
    The Journal of antimicrobial chemotherapy, 2000, Volume: 46, Issue:1

    Topics: Administration, Oral; Anti-Bacterial Agents; Bacteria; beta-Lactams; Carbapenems; Cephalosporins; Lactams; Microbial Sensitivity Tests

2000
Pseudomonas aeruginosa reveals high intrinsic resistance to penem antibiotics: penem resistance mechanisms and their interplay.
    Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:7

    Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Biological Transport; Carbapenems; Carrier Proteins; Escherichia coli; Humans; Lactams; Membrane Transport Proteins; Microbial Sensitivity Tests; Porins; Pseudomonas aeruginosa

2001
beta-Lactam-susceptibility patterns of Plesiomonas shigelloides strains: importance of inoculum and medium.
    Scandinavian journal of infectious diseases, 2001, Volume: 33, Issue:9

    Topics: Animals; Aztreonam; beta-Lactams; Carbapenems; Cephalosporins; Culture Media; Dogs; Humans; Microbial Sensitivity Tests; Penicillins; Plesiomonas

2001
Design, synthesis and bioactivity evaluation of tribactam beta lactamase inhibitors.
    Bioorganic & medicinal chemistry letters, 2002, Mar-25, Volume: 12, Issue:6

    Topics: Bacillus cereus; beta-Lactamase Inhibitors; beta-Lactams; Carbapenems; Dose-Response Relationship, Drug; Drug Design; Hydrolysis; Models, Molecular

2002
Efficient one-pot synthesis of the 2-aminocarbonylpyrrolidin-4-ylthio-containing side chain of the new broad-spectrum carbapenem antibiotic ertapenem.
    The Journal of organic chemistry, 2002, Jul-12, Volume: 67, Issue:14

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Carbapenems; Chromatography, High Pressure Liquid; Combinatorial Chemistry Techniques; Ertapenem; Lactams; Molecular Structure; Pyrrolidines; Stereoisomerism

2002
Intra-abdominal anaerobic infections: bacteriology and therapeutic potential of newer antimicrobial carbapenem, fluoroquinolone, and desfluoroquinolone therapeutic agents.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2002, Sep-01, Volume: 35, Issue:Suppl 1

    Topics: Abdominal Abscess; Anti-Bacterial Agents; Aza Compounds; Bacteremia; Bacteria, Anaerobic; Bacteroides fragilis; Bacteroides Infections; beta-Lactams; Carbapenems; Clinical Trials as Topic; Ertapenem; Fluoroquinolones; Gemifloxacin; Humans; Indoles; Lactams; Moxifloxacin; Naphthyridines; Quinolines; Quinolones

2002
In vitro activity of ertapenem (MK-0826) against multi-drug resistant Streptococcus pneumoniae compared with 13 other antimicrobials.
    International journal of antimicrobial agents, 2002, Volume: 20, Issue:2

    Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Drug Resistance, Multiple, Bacterial; Ertapenem; Humans; Lactams; Microbial Sensitivity Tests; Streptococcus pneumoniae

2002
Nosocomial infections caused by multidrug-resistant isolates of pseudomonas putida producing VIM-1 metallo-beta-lactamase.
    Journal of clinical microbiology, 2002, Volume: 40, Issue:11

    Topics: Aged; beta-Lactamases; beta-Lactams; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Integrons; Microbial Sensitivity Tests; Middle Aged; Molecular Sequence Data; Pseudomonas Infections; Pseudomonas putida; Urinary Tract Infections

2002
Inhibition of class A and class C beta-lactamases by penems: crystallographic structures of a novel 1,4-thiazepine intermediate.
    Biochemistry, 2003, Nov-18, Volume: 42, Issue:45

    Topics: Apoenzymes; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Binding Sites; Carbapenems; Computer Simulation; Crystallography, X-Ray; Enterobacter cloacae; Enzyme Inhibitors; Enzyme Stability; Klebsiella pneumoniae; Lactams; Models, Molecular; Thiazepines

2003
PBP 2a mutations producing very-high-level resistance to beta-lactams.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:2

    Topics: Amino Acid Substitution; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Blotting, Western; Carbapenems; Carrier Proteins; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Hexosyltransferases; Imidazoles; Methicillin Resistance; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Mutation; Penicillin-Binding Proteins; Peptidyl Transferases; Phenotype; Plasmids; Protein Binding; Staphylococcus aureus; Transformation, Bacterial

2004
Pharmacokinetics of total and unbound ertapenem in healthy elderly subjects.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:2

    Topics: Adult; Aged; Area Under Curve; beta-Lactams; Carbapenems; Creatinine; Ertapenem; Female; Half-Life; Humans; Injections, Intravenous; Lactams; Male; Spectrophotometry, Ultraviolet

2004
Comparative activity of beta-lactam agents (carbapenem excepted) against Pseudomonas aeruginosa strains with CARB or OXA beta-lactamases.
    Chemotherapy, 2004, Volume: 50, Issue:1

    Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Carrier Proteins; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Penicillinase; Pseudomonas aeruginosa

2004
[Carbapenemase detection in Acinetobacter baumannii clones resistant to imipenem].
    Enfermedades infecciosas y microbiologia clinica, 2004, Volume: 22, Issue:5

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Genotype; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Multicenter Studies as Topic; Spain; Thienamycins

2004
Treatment of complicated community-acquired infections with ertapenem, the first Group 1 carbapenem. Introduction.
    The Journal of antimicrobial chemotherapy, 2004, Volume: 53 Suppl 2

    Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; Carbapenems; Community-Acquired Infections; Drug Resistance, Bacterial; Ertapenem; Humans; Lactams

2004
Molecular characterization of a cephamycin-hydrolyzing and inhibitor-resistant class A beta-lactamase, GES-4, possessing a single G170S substitution in the omega-loop.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:8

    Topics: Amino Acid Sequence; Amino Acid Substitution; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Cephamycins; Cloning, Molecular; Conjugation, Genetic; Drug Resistance, Bacterial; Enzyme Inhibitors; Hydrolysis; Kinetics; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Transformation, Bacterial

2004
The influence of protein binding on the antibacterial activity of faropenem against Haemophilus influenzae.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2004, Volume: 10, Issue:10

    Topics: beta-Lactamases; beta-Lactams; Carbapenems; Colony Count, Microbial; Haemophilus Infections; Haemophilus influenzae; Humans; Lactams; Microbial Sensitivity Tests; Protein Binding; Serum Albumin; Serum Bactericidal Test

2004
IMP-1 metallo-beta-lactamase-producing Pseudomonas aeruginosa in a university hospital in the People's Republic of China.
    The Journal of antimicrobial chemotherapy, 2004, Volume: 54, Issue:6

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; China; Hospitals, University; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa

2004
Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model.
    The Journal of antimicrobial chemotherapy, 2004, Volume: 54, Issue:6

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Colistin; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Pneumonia, Bacterial; Rifampin; Tobramycin

2004
First detection of a carbapenem-hydrolyzing metalloenzyme in an Enterobacteriaceae isolate in France.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:12

    Topics: Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Enterobacteriaceae; Escherichia coli; France; Humans; Klebsiella pneumoniae; Male; Middle Aged; Penicillins; Plasmids

2004
Impact of positive legionella urinary antigen test on patient management and improvement of antibiotic use.
    Journal of clinical pathology, 2004, Volume: 57, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antigens, Bacterial; beta-Lactams; Carbapenems; Cephalosporins; Child, Preschool; Female; Humans; Immunoenzyme Techniques; Legionnaires' Disease; Macrolides; Male; Middle Aged; Retrospective Studies; Sensitivity and Specificity

2004
Clinical experiences of bacteremia caused by metallo-beta-lactamase-producing gram-negative organisms.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2004, Volume: 37, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Carbapenems; Child; Child, Preschool; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged

2004
Pharmacodynamic modeling of carbapenems and fluoroquinolones against bacteria that produce extended-spectrum beta-lactamases.
    Clinical therapeutics, 2004, Volume: 26, Issue:11

    Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Ciprofloxacin; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Fluoroquinolones; Gatifloxacin; Humans; Imipenem; Klebsiella pneumoniae; Lactams; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Models, Biological; Monte Carlo Method; Ofloxacin; Thienamycins

2004
Selectivity of ertapenem for Pseudomonas aeruginosa mutants cross-resistant to other carbapenems.
    The Journal of antimicrobial chemotherapy, 2005, Volume: 55, Issue:3

    Topics: beta-Lactams; Carbapenems; Culture Media, Serum-Free; Drug Resistance, Bacterial; Ertapenem; Lactams; Microbial Sensitivity Tests; Mutation; Porins; Pseudomonas aeruginosa

2005
Biosynthesis of tripyrrole and beta-lactam secondary metabolites in Serratia: integration of quorum sensing with multiple new regulatory components in the control of prodigiosin and carbapenem antibiotic production.
    Molecular microbiology, 2005, Volume: 56, Issue:6

    Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactams; Carbapenems; Gene Expression Regulation, Bacterial; Molecular Sequence Data; Prodigiosin; Promoter Regions, Genetic; Serratia; Transcription, Genetic

2005
Amino acid residues that contribute to substrate specificity of class A beta-lactamase SME-1.
    Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:8

    Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Binding Sites; Carbapenems; Cefotaxime; Codon; Escherichia coli; Imipenem; Kinetics; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Mutagenesis, Site-Directed; Penicillins; Substrate Specificity

2005
Quantification of the carbapenem antibiotic ertapenem in human plasma by a validated liquid chromatography-mass spectrometry method.
    Clinica chimica acta; international journal of clinical chemistry, 2006, Volume: 364, Issue:1-2

    Topics: beta-Lactams; Calibration; Carbapenems; Chromatography, High Pressure Liquid; Drug Stability; Ertapenem; Humans; Kidney Failure, Chronic; Mass Spectrometry; Reference Standards; Reproducibility of Results

2006
The enzymology of clavam and carbapenem biosynthesis.
    Chemical communications (Cambridge, England), 2005, Sep-14, Issue:34

    Topics: Amino Acids; beta-Lactams; Carbapenems; Clavulanic Acids; Enzymes; Indicators and Reagents; Models, Molecular; Molecular Conformation; Oxidation-Reduction

2005
Multicentre survey of the in-vitro activity of seven antimicrobial agents, including ertapenem, against recently isolated Gram-negative anaerobic bacteria in Greece.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2005, Volume: 11, Issue:10

    Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides fragilis; beta-Lactams; Carbapenems; Drug Resistance, Microbial; Ertapenem; Gram-Negative Anaerobic Bacteria; Gram-Negative Bacterial Infections; Greece; Humans; Inhibitory Concentration 50; Metronidazole; Microbial Sensitivity Tests

2005
In vitro activities of doripenem and comparator agents against 364 anaerobic clinical isolates.
    Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:10

    Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; beta-Lactams; Carbapenems; Doripenem; Ertapenem; Humans; Imipenem; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Ofloxacin; Thienamycins

2005
Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991-2003 at a university hospital in Taiwan.
    International journal of antimicrobial agents, 2005, Volume: 26, Issue:6

    Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals, University; Humans; Incidence; Length of Stay; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Taiwan

2005
Delayed resistance selection for doripenem when passaging Pseudomonas aeruginosa isolates with doripenem plus an aminoglycoside.
    Diagnostic microbiology and infectious disease, 2006, Volume: 55, Issue:3

    Topics: Aminoglycosides; beta-Lactam Resistance; beta-Lactams; Carbapenems; Doripenem; Drug Interactions; Gentamicins; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa

2006
A theoretical proposal for the synthesis of carbapenems from 4-(2-propynyl)azetidinones promoted by [W(CO)5] as an alternative to the Ag+-assisted process.
    Chemistry (Weinheim an der Bergstrasse, Germany), 2006, Oct-16, Volume: 12, Issue:30

    Topics: Anti-Bacterial Agents; Azetidines; Carbapenems; Hydrolysis; Models, Chemical; Silver; Thermodynamics; Tungsten Compounds

2006
Frequency and predictors of colonization of the respiratory tract by VIM-2-producing Pseudomonas aeruginosa in patients of a newly established intensive care unit.
    Journal of medical microbiology, 2006, Volume: 55, Issue:Pt 10

    Topics: Acute Disease; beta-Lactamases; beta-Lactams; Bronchi; Carbapenems; Carrier State; Cross Infection; Female; Genes, Bacterial; Gram-Negative Bacteria; Greece; Hospitals, General; Humans; Intensive Care Units; Male; Middle Aged; Polymerase Chain Reaction; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Time Factors; Trachea; Urban Population

2006
Comparative in vitro activity of ertapenem against extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolated in Spain.
    International journal of antimicrobial agents, 2006, Volume: 28, Issue:5

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Ertapenem; Escherichia coli; Humans; Imipenem; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Spain; Thienamycins

2006
In vitro activities of three carbapenems against recent bacterial isolates from severely ill patients at Swedish hospitals.
    Scandinavian journal of infectious diseases, 2006, Volume: 38, Issue:10

    Topics: Acinetobacter; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Carbapenems; Enterobacteriaceae; Ertapenem; Gram-Negative Bacterial Infections; Humans; Imipenem; Klebsiella; Meropenem; Microbial Sensitivity Tests; Proteus; Sweden; Thienamycins

2006
Effect of carbapenem administration on establishment of intestinal colonization by vancomycin-resistant enterococci and Klebsiella pneumoniae in mice.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:1

    Topics: Animals; beta-Lactams; Carbapenems; Ceftriaxone; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Enterococcus; Ertapenem; Female; Imipenem; Intestines; Klebsiella pneumoniae; Mice; Piperacillin; Sodium Chloride; Time Factors; Vancomycin Resistance

2007
The impact of an antibiotic cycling program on empirical therapy for gram-negative infections.
    Chest, 2006, Volume: 130, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Carbapenems; Cephalosporins; Cross Infection; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Resistance, Multiple; Empiricism; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Hospitals, Teaching; Humans; Intensive Care Units; Male; Middle Aged; Missouri; Penicillins; Pneumonia, Bacterial; Prospective Studies; Survival Rate; Urinary Tract Infections; Ventilators, Mechanical

2006
Ertapenem resistance among Klebsiella and Enterobacter submitted in the UK to a reference laboratory.
    International journal of antimicrobial agents, 2007, Volume: 29, Issue:4

    Topics: Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacter; Ertapenem; Humans; Klebsiella; Laboratories; Microbial Sensitivity Tests; United Kingdom

2007
Is combination therapy with betalactam plus aminoglycoside (AGL) improving the outcome of nosocomial meningitis in children?
    Neuro endocrinology letters, 2007, Volume: 28 Suppl 2

    Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Child; Child, Preschool; Cross Infection; Drug Therapy, Combination; Glycopeptides; Humans; Infant; Infant, Newborn; Meningitis, Bacterial; Prognosis; Retrospective Studies; Treatment Outcome

2007
Insufficient therapy for nosocomial meningitis negatively affects survival, sequellae and has social consequences.
    Neuro endocrinology letters, 2007, Volume: 28 Suppl 2

    Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Child; Child, Preschool; Cross Infection; Drug Therapy, Combination; Humans; Infant; Infant, Newborn; Meningitis, Bacterial; Retrospective Studies; Treatment Failure; Vancomycin

2007
Multidrug-resistant Acinetobacter baumannii, Russia.
    Emerging infectious diseases, 2007, Volume: 13, Issue:4

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Drug Resistance, Multiple, Bacterial; France; Humans; Male; Microbial Sensitivity Tests; Patient Transfer; Russia

2007
Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:11

    Topics: Acinetobacter; Acinetobacter Infections; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Blotting, Southern; Carbapenems; China; Chloramphenicol; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Hospitals; Humans; Imipenem; Integrons; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Sequence Data; Rifampin; Sequence Analysis, DNA

2007
Outbreak of carbapenem-resistant Klebsiella pneumoniae producing KPC-3 in a tertiary medical centre in Israel.
    International journal of antimicrobial agents, 2007, Volume: 30, Issue:6

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Disease Outbreaks; Hospitals, University; Humans; Israel; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymerase Chain Reaction; Random Amplified Polymorphic DNA Technique; Sequence Analysis, DNA

2007
[Bacteria isolated from perforation peritonitis and their antimicrobial susceptibilities].
    The Japanese journal of antibiotics, 2007, Volume: 60, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Intestinal Perforation; Male; Middle Aged; Peritonitis

2007
Plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in Klebsiella pneumoniae isolate from Greece.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:2

    Topics: Adult; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Female; Greece; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids

2008
Antimicrobial activities of Ceftaroline and ME1036 tested against clinical strains of community-acquired methicillin-resistant Staphylococcus aureus.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:3

    Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Ceftaroline; Cephalosporins; Community-Acquired Infections; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; United States

2008
Are beta-lactams related to higher morbidity and mortality in urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli?
    The Journal of hospital infection, 2008, Volume: 68, Issue:2

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Escherichia coli; Escherichia coli Infections; Hong Kong; Humans; Retrospective Studies; Treatment Outcome; Urinary Tract Infections

2008
Activity of doripenem and comparator beta-lactams against US clinical isolates of Streptococcus pneumoniae with defined mutations in the penicillin-binding domains of pbp1a, pbp2b and pbp2x.
    The Journal of antimicrobial chemotherapy, 2008, Volume: 61, Issue:3

    Topics: Aminoacyltransferases; Bacterial Proteins; beta-Lactams; Carbapenems; Doripenem; Humans; Mutation; Penicillin-Binding Proteins; Penicillins; Peptidyl Transferases; Protein Binding; Protein Structure, Tertiary; Streptococcus pneumoniae; United States

2008
Affinity of doripenem and comparators to penicillin-binding proteins in Escherichia coli and Pseudomonas aeruginosa.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:4

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Carbapenems; Doripenem; Escherichia coli; Escherichia coli Proteins; Humans; Inhibitory Concentration 50; Microbial Sensitivity Tests; Penicillin-Binding Proteins; Pseudomonas aeruginosa

2008
Cyslabdan, a new potentiator of imipenem activity against methicillin-resistant Staphylococcus aureus, produced by Streptomyces sp. K04-0144. II. Biological activities.
    The Journal of antibiotics, 2008, Volume: 61, Issue:1

    Topics: Acetylcysteine; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Diterpenes; Drug Synergism; Humans; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Molecular Structure; Staphylococcus aureus; Streptomyces

2008
Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli Isolates possessing the plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in intensive care units of a Chinese hospital.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:6

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; China; Conjugation, Genetic; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Hospitals, University; Humans; Hydrolysis; Intensive Care Units; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction; Serratia marcescens

2008
Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae isolates from Turkey with OXA-48-like carbapenemases and outer membrane protein loss.
    International journal of antimicrobial agents, 2008, Volume: 31, Issue:6

    Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Porins; Reverse Transcriptase Polymerase Chain Reaction; Transformation, Bacterial; Turkey

2008
Comparison of the efficacies of oral beta-lactams in selection of Haemophilus influenzae transformants with mutated ftsI genes.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:5

    Topics: Ampicillin; Bacterial Proteins; beta-Lactams; Carbapenems; Cefdinir; Cefprozil; Cephalosporins; Gene Transfer, Horizontal; Haemophilus influenzae; Mutation; Penicillin-Binding Proteins

2008
Crystal structures of biapenem and tebipenem complexed with penicillin-binding proteins 2X and 1A from Streptococcus pneumoniae.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:6

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Binding Sites; Carbapenems; Crystallization; Crystallography, X-Ray; Models, Molecular; Molecular Structure; Penicillin-Binding Proteins; Peptidyl Transferases; Protein Binding; Streptococcus pneumoniae; Thienamycins

2008
In vitro activity of ertapenem and other carbapenems against extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae clinical isolates in a tertiary care center in Turkey.
    Expert opinion on pharmacotherapy, 2008, Volume: 9, Issue:9

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Child; Child, Preschool; Ertapenem; Escherichia coli; Female; Hospitals, University; Humans; Infant; Infant, Newborn; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Turkey

2008
Restoration of susceptibility of intracellular methicillin-resistant Staphylococcus aureus to beta-lactams: comparison of strains, cells, and antibiotics.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:8

    Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cefepime; Cefuroxime; Cell Line; Cells, Cultured; Cephalosporins; Cloxacillin; Humans; Hydrogen-Ion Concentration; Imipenem; Meropenem; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Oxacillin; Phagocytosis; Staphylococcus aureus; Thienamycins

2008
[Childhood bacterial meningitis trends in Japan from 2005 to 2006].
    Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 2008, Volume: 82, Issue:3

    Topics: Adolescent; Age Distribution; Ampicillin; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cephalosporins; Child; Child, Preschool; Drug Resistance; Drug Therapy, Combination; Escherichia coli; Female; Haemophilus influenzae; Humans; Infant; Infant, Newborn; Japan; Male; Meningitis, Bacterial; Streptococcus pneumoniae; Time Factors

2008
Plasmid-encoded carbapenem-hydrolyzing beta-lactamase OXA-48 in an imipenem-susceptible Klebsiella pneumoniae strain from Belgium.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:9

    Topics: Adult; Anti-Bacterial Agents; Belgium; beta-Lactamases; beta-Lactams; Carbapenems; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Plasmids

2008
Trends in Stenotrophomonas maltophilia bloodstream infection in relation to usage density of cephalosporins and carbapenems during 7 years.
    Infection control and hospital epidemiology, 2008, Volume: 29, Issue:10

    Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Brazil; Carbapenems; Cephalosporins; Gram-Negative Bacterial Infections; Hospitals, University; Humans; Incidence; Stenotrophomonas maltophilia

2008
Simultaneous determination of three carbapenem antibiotics in plasma by HPLC with ultraviolet detection.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2008, Nov-15, Volume: 875, Issue:2

    Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Ceftazidime; Chromatography, High Pressure Liquid; Drug Stability; Ertapenem; Humans; Imipenem; Meropenem; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Thienamycins

2008
Carbapenems and SHV-1 beta-lactamase form different acyl-enzyme populations in crystals and solution.
    Biochemistry, 2008, Nov-11, Volume: 47, Issue:45

    Topics: beta-Lactamases; beta-Lactams; Carbapenems; Crystallography, X-Ray; Ertapenem; Imipenem; Meropenem; Molecular Structure; Solutions; Spectrum Analysis, Raman; Thienamycins

2008
Presence of the KPC carbapenemase gene in Enterobacteriaceae causing bacteremia and its correlation with in vitro carbapenem susceptibility.
    Journal of clinical microbiology, 2009, Volume: 47, Issue:1

    Topics: Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Microbial Sensitivity Tests; Middle Aged; Missouri; Predictive Value of Tests

2009
Carbapenems versus other beta-lactams in the treatment of hospitalised patients with infection: a mixed treatment comparison.
    Current medical research and opinion, 2009, Volume: 25, Issue:1

    Topics: beta-Lactams; Carbapenems; Hospitalization; Humans; Infections; Inpatients; Randomized Controlled Trials as Topic

2009
Detection of blaOXA-58 and blaOXA-23-like genes in carbapenem-susceptible Acinetobacter clinical isolates: should we be concerned?
    Journal of medical microbiology, 2009, Volume: 58, Issue:Pt 6

    Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Humans; Ireland; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA

2009
GES-11, a novel integron-associated GES variant in Acinetobacter baumannii.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:8

    Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Aztreonam; beta-Lactamases; beta-Lactams; Carbapenems; Integrons; Microbial Sensitivity Tests; Models, Genetic; Molecular Sequence Data; Plasmids

2009
Re: A VIM-1-metallo-beta-lactamase-producing Klebsiella pneumoniae clinical isolate in an acute hospital in Germany.
    International journal of antimicrobial agents, 2009, Volume: 34, Issue:4

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Germany; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests

2009
Klebsiellapneumoniae isolates possessing KPC beta-lactamase in Israel, Puerto Rico, Colombia and Greece.
    International journal of antimicrobial agents, 2009, Volume: 34, Issue:4

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Colombia; Drug Resistance, Bacterial; Greece; Humans; Israel; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Minocycline; Population Surveillance; Puerto Rico; Tigecycline

2009
Novel VIM metallo-beta-lactamase variant from clinical isolates of Enterobacteriaceae from Algeria.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:1

    Topics: Algeria; Anti-Bacterial Agents; Base Sequence; beta-Lactamases; beta-Lactams; Carbapenems; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Genome, Bacterial; Hospitals, Military; Imipenem; Isoelectric Focusing; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillins; Phenotype

2010
Mutant prevention concentrations of four carbapenems against gram-negative rods.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:6

    Topics: Acinetobacter baumannii; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Doripenem; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Genes, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; In Vitro Techniques; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Mutation; Phenotype; Pseudomonas aeruginosa; Thienamycins

2010
Absence of association between use of ertapenem and change in antipseudomonal carbapenem susceptibility rates in 25 hospitals.
    Infection control and hospital epidemiology, 2010, Volume: 31, Issue:5

    Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Drug Resistance, Bacterial; Ertapenem; Hospitals; Hospitals, Teaching; Humans; Microbial Sensitivity Tests; Practice Patterns, Physicians'; Pseudomonas aeruginosa; Pseudomonas Infections; United States

2010
Biochemical and structural characterization of Mycobacterium tuberculosis beta-lactamase with the carbapenems ertapenem and doripenem.
    Biochemistry, 2010, May-04, Volume: 49, Issue:17

    Topics: beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Crystallization; Crystallography, X-Ray; Cyclotrons; Doripenem; Ertapenem; Fourier Analysis; Hydrogen Bonding; Indicators and Reagents; Kinetics; Mass Spectrometry; Models, Molecular; Molecular Structure; Mycobacterium tuberculosis; Protein Conformation

2010
Detection of a common plasmid carrying blaKPC-2 in Enterobacteriaceae isolates from distinct cities in China.
    Microbial drug resistance (Larchmont, N.Y.), 2010, Volume: 16, Issue:4

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; China; Electrophoresis, Gel, Pulsed-Field; Enterobacter cloacae; Enterobacteriaceae Infections; Escherichia coli; Hospitals, Urban; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids; Polymerase Chain Reaction

2010
Antimicrobial stewardship lessons: do Pseudomonas-sparing agents, such as ertapenem, effectively improve bacterial resistance?
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:7

    Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Ertapenem; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Sulbactam

2010
Prevalence and characteristics of ertapenem-nonsusceptible Escherichia coli in a Taiwanese university hospital, 1999 to 2007.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2010, Volume: 29, Issue:11

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporinase; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Hospitals, University; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Porins; Taiwan

2010
OXA-134, a naturally occurring carbapenem-hydrolyzing class D beta-lactamase from Acinetobacter lwoffii.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:12

    Topics: Acinetobacter; Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Escherichia coli; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Sequence Homology, Amino Acid

2010
Ferrier-Petasis rearrangement of 4-(vinyloxy)azetidin-2-ones: an entry to carbapenams and carbacephams.
    The Journal of organic chemistry, 2010, Oct-15, Volume: 75, Issue:20

    Topics: Azetidines; Carbapenems; Cephalosporins; Molecular Conformation; Stereoisomerism

2010
Risk factors for the acquisition of nosocomial infection with carbapenem-resistant Klebsiella pneumoniae.
    Southern medical journal, 2011, Volume: 104, Issue:2

    Topics: Age Factors; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Case-Control Studies; Chi-Square Distribution; Confidence Intervals; Cross Infection; Drug Resistance, Bacterial; Ertapenem; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Logistic Models; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Odds Ratio; Risk Factors; Thienamycins

2011
New Delhi metallo-beta-lactamase from traveler returning to Canada.
    Emerging infectious diseases, 2011, Volume: 17, Issue:2

    Topics: Adult; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Canada; Carbapenems; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Fosfomycin; Humans; India; Male; Microbial Sensitivity Tests; Prostatitis; Pyelonephritis; Travel; Urine

2011
Phenotypic and genotypic screening and clonal analysis of carbapenem-resistant Klebsiella pneumoniae at a single hospital.
    Microbial drug resistance (Larchmont, N.Y.), 2011, Volume: 17, Issue:2

    Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; DNA, Bacterial; Doripenem; Electrophoresis, Gel, Pulsed-Field; Ertapenem; Genotype; Hospitals, Urban; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Phylogeny; Polymerase Chain Reaction; Sensitivity and Specificity; Thienamycins; United States

2011
[Investigation of the susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. strains to ertapenem and other carbapenems].
    Mikrobiyoloji bulteni, 2011, Volume: 45, Issue:1

    Topics: Amikacin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Klebsiella Infections; Klebsiella oxytoca; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Thienamycins

2011
Carbapenem therapy for bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae.
    Diagnostic microbiology and infectious disease, 2011, Volume: 70, Issue:1

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Carbapenems; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Middle Aged; Thienamycins; Treatment Outcome

2011
Change in antipseudomonal carbapenem susceptibility in 25 hospitals across 9 years is not associated with the use of ertapenem.
    The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:6

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Carbapenems; Drug Utilization; Ertapenem; Hospitals; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections

2011
Comparative in vitro susceptibility of Burkholderia pseudomallei to doripenem, ertapenem, tigecycline and moxifloxacin.
    International journal of antimicrobial agents, 2011, Volume: 37, Issue:6

    Topics: Anti-Bacterial Agents; Aza Compounds; beta-Lactams; Burkholderia pseudomallei; Carbapenems; Doripenem; Ertapenem; Fluoroquinolones; Humans; Melioidosis; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Quinolines; Tigecycline

2011
Clinical epidemiology of carbapenem-intermediate or -resistant Enterobacteriaceae.
    The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:7

    Topics: Academic Medical Centers; Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Carbapenems; Case-Control Studies; Drug Utilization; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Female; Humans; Male; Meropenem; Middle Aged; Risk Factors; Thienamycins

2011
[Interpretation of the susceptibility test results in enterobacteria producing 3rd- and 4th-generation cephalosporin- or carbapenem-hydrolyzing beta-lactamases].
    Epidemiologie, mikrobiologie, imunologie : casopis Spolecnosti pro epidemiologii a mikrobiologii Ceske lekarske spolecnosti J.E. Purkyne, 2011, Volume: 60, Issue:1

    Topics: beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Enterobacteriaceae; Hydrolysis; Microbial Sensitivity Tests

2011
Real-time TaqMan PCR for rapid detection of genes encoding five types of non-metallo- (class A and D) carbapenemases in Enterobacteriaceae.
    International journal of antimicrobial agents, 2011, Volume: 38, Issue:1

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Chromatography, Gel; DNA Primers; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Taq Polymerase; Time Factors; Transition Temperature

2011
Hand hygiene, and not ertapenem use, contributed to reduction of carbapenem-resistant Pseudomonas aeruginosa rates.
    Infection control and hospital epidemiology, 2011, Volume: 32, Issue:6

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Carbapenems; Cross Infection; Ertapenem; Hand Disinfection; Hospitals, University; Humans; Incidence; Pseudomonas aeruginosa; Pseudomonas Infections; Regression Analysis

2011
Analysis of resistance, cross-resistance and antimicrobial combinations for Pseudomonas aeruginosa isolates from 1997 to 2009.
    International journal of antimicrobial agents, 2011, Volume: 38, Issue:4

    Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Carbapenems; Cephalosporins; Cross Infection; Databases, Factual; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; United States

2011
Does ertepenem alter the susceptibility of Pseudomonas aeruginosa to carbapenems?
    Journal of chemotherapy (Florence, Italy), 2011, Volume: 23, Issue:4

    Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Drug Interactions; Ertapenem; Humans; Intensive Care Units; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections

2011
[Clinical efficacy of tebipenem pivoxil treatment in children with pneumonia, who had no relief despite having administered oral beta-lactam antibiotics].
    The Japanese journal of antibiotics, 2011, Volume: 64, Issue:3

    Topics: Administration, Oral; Amdinocillin Pivoxil; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Child, Preschool; Drug Administration Schedule; Drug Combinations; Drug Resistance, Bacterial; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Male; Pneumonia, Bacterial; Streptococcal Infections; Streptococcus pneumoniae; Treatment Failure; Treatment Outcome

2011
Reduction in fluoroquinolone use following introduction of ertapenem into a hospital formulary is associated with improvement in susceptibility of Pseudomonas aeruginosa to group 2 carbapenems: a 10-year study.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:12

    Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Ertapenem; Fluoroquinolones; Formularies, Hospital as Topic; Hospitals, Teaching; Humans; Microbial Sensitivity Tests; North Carolina; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies

2011
Ertapenem in the treatment of bacteremia caused by extended-spectrum beta-lactamase-producing Escherichia coli: a propensity score analysis.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2012, Volume: 16, Issue:1

    Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Carbapenems; Ertapenem; Escherichia coli; Female; Humans; Imipenem; Male; Meropenem; Middle Aged; Propensity Score; Thienamycins

2012
The class A β-lactamase FTU-1 is native to Francisella tularensis.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:2

    Topics: Amino Acid Sequence; Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Escherichia coli; Francisella tularensis; Humans; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data

2012
First detection of blaIMI-2 gene in a clinical Escherichia coli strain.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:2

    Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Sepsis; Sequence Analysis, DNA

2012
Tn125-related acquisition of blaNDM-like genes in Acinetobacter baumannii.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:2

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Gene Transfer, Horizontal; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA; Switzerland

2012
Cefoxitin as an alternative to carbapenems in a murine model of urinary tract infection due to Escherichia coli harboring CTX-M-15-type extended-spectrum β-lactamase.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:3

    Topics: Animals; Anti-Bacterial Agents; Bacterial Load; beta-Lactamases; beta-Lactams; Carbapenems; Cefoxitin; Ceftriaxone; Conjugation, Genetic; Disease Models, Animal; Drug Administration Schedule; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Kidney; Mice; Microbial Sensitivity Tests; Mutation Rate; Plasmids; Urinary Bladder; Urinary Tract Infections

2012
Nosocomial outbreak of carbapenem-resistant Enterobacter cloacae highlighting the interspecies transferability of the blaOXA-48 gene in the gut flora.
    The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:4

    Topics: Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Cross Infection; Disease Outbreaks; Enterobacter cloacae; Enterobacteriaceae Infections; Gastrointestinal Tract; Gene Transfer, Horizontal; Humans; Microbial Sensitivity Tests

2012
Carbapenem resistance in Elizabethkingia meningoseptica is mediated by metallo-β-lactamase BlaB.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:4

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Chryseobacterium; DNA Primers; DNA, Recombinant; Drug Resistance, Bacterial; Gene Expression Regulation, Bacterial; Immunoprecipitation; Real-Time Polymerase Chain Reaction; RNA, Bacterial

2012
Development of carbapenem resistance during therapy for non-typhoid Salmonella infection.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2012, Volume: 18, Issue:4

    Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Ertapenem; Feces; Female; Humans; Microbial Sensitivity Tests; Plasmids; Point Mutation; Porins; RNA, Bacterial; Salmonella Infections; Salmonella typhimurium; Urinary Tract Infections; Wound Infection

2012
A high-throughput screen for the engineered production of β-lactam antibiotics.
    ACS chemical biology, 2012, May-18, Volume: 7, Issue:5

    Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Carbon-Nitrogen Ligases; High-Throughput Screening Assays; Industrial Microbiology; Models, Molecular; Mutation; Pectobacterium carotovorum; Protein Engineering

2012
Class A carbapenemase FPH-1 from Francisella philomiragia.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:6

    Topics: Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Clavulanic Acid; Doripenem; Ertapenem; Escherichia coli; Francisella; Imipenem; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Sulbactam; Tazobactam; Thienamycins

2012
Risk factors, molecular epidemiology and outcomes of ertapenem-resistant, carbapenem-susceptible Enterobacteriaceae: a case-case-control study.
    PloS one, 2012, Volume: 7, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Case-Control Studies; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Female; Humans; Logistic Models; Male; Middle Aged; Molecular Epidemiology; Multivariate Analysis; Risk Factors; Singapore; Treatment Outcome; Young Adult

2012
Use of Carbapenems against clinical, nontyphoid Salmonella isolates: results from in vitro and in vivo animal studies.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:6

    Topics: Animals; beta-Lactams; Carbapenems; Cell Line; Doripenem; Ertapenem; Female; Imipenem; Meropenem; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Peritonitis; Salmonella; Thienamycins

2012
Sequence type 101 (ST101) as the predominant carbapenem-non-susceptible Klebsiella pneumoniae clone in an acute general hospital in Italy.
    International journal of antimicrobial agents, 2012, Volume: 39, Issue:6

    Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Hospitals, General; Humans; Imipenem; Italy; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests

2012
Prevalence and diversity of carbapenem-resistant bacteria in untreated drinking water in Portugal.
    Microbial drug resistance (Larchmont, N.Y.), 2012, Volume: 18, Issue:5

    Topics: Anti-Bacterial Agents; Bacteria; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Colony Count, Microbial; Drinking Water; Humans; Microbial Sensitivity Tests; Phylogeny; Portugal; Prevalence

2012
Correlation between carbapenem consumption and resistance to carbapenems among Enterobacteriaceae isolates collected from patients with intra-abdominal infections at five medical centers in Taiwan, 2006-2010.
    International journal of antimicrobial agents, 2012, Volume: 40 Suppl

    Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Intraabdominal Infections; Linear Models; Meropenem; Microbial Sensitivity Tests; Prevalence; Prospective Studies; Taiwan; Thienamycins

2012
Epidemiology and antimicrobial susceptibility profiles of Gram-negative bacteria causing urinary tract infections in the Asia-Pacific region: 2009-2010 results from the Study for Monitoring Antimicrobial Resistance Trends (SMART).
    International journal of antimicrobial agents, 2012, Volume: 40 Suppl

    Topics: Amikacin; Anti-Bacterial Agents; Asia; Australasia; beta-Lactamases; beta-Lactams; Carbapenems; Ceftazidime; Drug Resistance, Bacterial; Ertapenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prevalence; Prospective Studies; Urinary Tract Infections

2012
Impact of revised CLSI breakpoints for susceptibility to third-generation cephalosporins and carbapenems among Enterobacteriaceae isolates in the Asia-Pacific region: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2002-2010
    International journal of antimicrobial agents, 2012, Volume: 40 Suppl

    Topics: Anti-Bacterial Agents; Asia; Australasia; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Intraabdominal Infections; Microbial Sensitivity Tests; Prevalence; Prospective Studies

2012
Kinetic and crystallographic studies of extended-spectrum GES-11, GES-12, and GES-14 β-lactamases.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:11

    Topics: Acinetobacter baumannii; Amino Acid Substitution; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Cloning, Molecular; Crystallography, X-Ray; Escherichia coli; Isoenzymes; Kinetics; Models, Molecular; Mutation; Recombinant Proteins; Structure-Activity Relationship

2012
Association of ertapenem and antipseudomonal carbapenem usage and carbapenem resistance in Pseudomonas aeruginosa among 12 hospitals in Queensland, Australia.
    The Journal of antimicrobial chemotherapy, 2013, Volume: 68, Issue:2

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Carbapenems; Drug Utilization; Ertapenem; Hospitals; Humans; Pseudomonas aeruginosa; Queensland

2013
[Comparison of ertapenem-EMB Agar with traditional methods for screening carbapenem-resistant Klebsiella pneumoniae from rectal swabs].
    Mikrobiyoloji bulteni, 2012, Volume: 46, Issue:4

    Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Culture Media; Doripenem; Drug Resistance, Bacterial; Ertapenem; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Multiplex Polymerase Chain Reaction; Rectum; Sensitivity and Specificity; Thienamycins; Time Factors

2012
Genome sequence of OXA-48 carbapenemase-producing Klebsiella pneumoniae KpO3210.
    Journal of bacteriology, 2012, Volume: 194, Issue:24

    Topics: Bacterial Proteins; beta-Lactamases; beta-Lactams; Blood; Carbapenems; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Genome, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA

2012
The use of UV, FT-IR and Raman spectra for the identification of the newest penem analogs: solutions based on mathematic procedure and the density functional theory.
    Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2013, Feb-15, Volume: 103

    Topics: beta-Lactams; Carbapenems; Doripenem; Models, Molecular; Quantum Theory; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis, Raman; Thienamycins

2013
KPC presence in Pseudomonas aeruginosa has minimal impact on the in vivo efficacy of carbapenem therapy.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Doripenem; Ertapenem; Mice; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections

2013
Genetic and biochemical characterisation of OXA-232, a carbapenem-hydrolysing class D β-lactamase from Enterobacteriaceae.
    International journal of antimicrobial agents, 2013, Volume: 41, Issue:4

    Topics: Amino Acid Substitution; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Enterobacteriaceae; Escherichia coli; France; Humans; India; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Polymerase Chain Reaction; Sequence Analysis, DNA

2013
The outcome of treating ESBL infections with carbapenems vs. non carbapenem antimicrobials.
    The Journal of the Association of Physicians of India, 2012, Volume: 60

    Topics: Adult; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; India; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Tertiary Healthcare; Treatment Outcome

2012
Comprehensive analysis of ß-lactam antibiotics including penicillins, cephalosporins, and carbapenems in poultry muscle using liquid chromatography coupled to tandem mass spectrometry.
    Analytical and bioanalytical chemistry, 2013, Volume: 405, Issue:24

    Topics: Animals; Anti-Infective Agents; beta-Lactams; Carbapenems; Cephalosporins; Chromatography, Liquid; Limit of Detection; Muscle, Skeletal; Penicillins; Poultry; Tandem Mass Spectrometry

2013
Effectiveness of a double-carbapenem regimen for infections in humans due to carbapenemase-producing pandrug-resistant Klebsiella pneumoniae.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:5

    Topics: Adult; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Doripenem; Drug Combinations; Drug Resistance, Bacterial; Ertapenem; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Middle Aged; Thienamycins; Treatment Outcome; Urinary Tract Infections

2013
Complete sequence of the bla(NDM-1)-carrying plasmid pNDM-AB from Acinetobacter baumannii of food animal origin.
    The Journal of antimicrobial chemotherapy, 2013, Volume: 68, Issue:7

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; DNA, Bacterial; Gene Order; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Sequence Analysis, DNA; Swine; Swine Diseases; Synteny

2013
Rapid selection of carbapenem-resistant Pseudomonas aeruginosa by clinical concentrations of ertapenem.
    International journal of antimicrobial agents, 2013, Volume: 41, Issue:5

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Carbapenems; Ertapenem; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Selection, Genetic

2013
Efficacy of doripenem and ertapenem against KPC-2-producing and non-KPC-producing Klebsiella pneumoniae with similar MICs.
    The Journal of antimicrobial chemotherapy, 2013, Volume: 68, Issue:7

    Topics: Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Disease Models, Animal; Doripenem; Ertapenem; Klebsiella Infections; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests; Treatment Outcome

2013
Frequent emergence of porin-deficient subpopulations with reduced carbapenem susceptibility in ESBL-producing Escherichia coli during exposure to ertapenem in an in vitro pharmacokinetic model.
    The Journal of antimicrobial chemotherapy, 2013, Volume: 68, Issue:6

    Topics: Anti-Bacterial Agents; Bacterial Load; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Kinetics; Microbial Sensitivity Tests; Mutation; Polymerase Chain Reaction; Porins; Trans-Activators

2013
A practical preparation of the key intermediate for penems and carbapenems synthesis.
    The Journal of antibiotics, 2013, Volume: 66, Issue:3

    Topics: Ammonia; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Lactams; Lithium; Organometallic Compounds; Oxidation-Reduction; Sodium; Stereoisomerism

2013
Reply to Soman et al and Frippiat et al.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2013, Volume: 57, Issue:2

    Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbapenems; Female; Humans; Male; Penicillanic Acid; Piperacillin; Sepsis

2013
Are prolonged/continuous infusions of β-lactams for all?
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2013, Volume: 57, Issue:2

    Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbapenems; Female; Humans; Male; Penicillanic Acid; Piperacillin; Sepsis

2013
Successful ertapenem-doripenem combination treatment of bacteremic ventilator-associated pneumonia due to colistin-resistant KPC-producing Klebsiella pneumoniae.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:6

    Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Carbapenems; Colistin; Doripenem; Drug Resistance, Bacterial; Drug Therapy, Combination; Ertapenem; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Pneumonia, Ventilator-Associated; Treatment Outcome

2013
Prevalence of β-lactamase-encoding genes among Enterobacteriaceae bacteremia isolates collected in 26 U.S. hospitals: report from the SENTRY Antimicrobial Surveillance Program (2010).
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:7

    Topics: Bacteremia; Bacterial Proteins; Base Sequence; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; DNA, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Genotype; Hospitals; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Promoter Regions, Genetic; Sequence Analysis, DNA; United States

2013
Efficacy of humanized carbapenem exposures against New Delhi metallo-β-lactamase (NDM-1)-producing enterobacteriaceae in a murine infection model.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:8

    Topics: Animals; Anti-Bacterial Agents; Bacterial Load; beta-Lactamases; beta-Lactams; Carbapenems; Disease Models, Animal; Doripenem; Drug Evaluation, Preclinical; Drug Resistance, Bacterial; Ertapenem; Humans; Klebsiella Infections; Klebsiella pneumoniae; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Neutropenia; Time Factors

2013
In vitro cross-linking of Mycobacterium tuberculosis peptidoglycan by L,D-transpeptidases and inactivation of these enzymes by carbapenems.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:12

    Topics: Antitubercular Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Cell Wall; Clavulanic Acid; Doripenem; Enzyme Assays; Ertapenem; Escherichia coli; Gene Expression; Imipenem; Kinetics; Meropenem; Mycobacterium tuberculosis; Peptidoglycan; Peptidyl Transferases; Recombinant Proteins; Thienamycins

2013
Epidemiology, antibiotic therapy and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in cancer patients.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2014, Volume: 22, Issue:3

    Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Bacteria; beta-Lactams; Carbapenems; Drug Resistance, Bacterial; Female; Humans; Male; Middle Aged; Neoplasms

2014
Evaluation of Ertapenem use with impact assessment on extended-spectrum beta-lactamases (ESBL) production and gram-negative resistance in Singapore General Hospital (SGH).
    BMC infectious diseases, 2013, Nov-06, Volume: 13

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Ertapenem; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals, General; Humans; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Singapore; Thienamycins; Young Adult

2013
A kinetic analysis of the inhibition of FOX-4 β-lactamase, a plasmid-mediated AmpC cephalosporinase, by monocyclic β-lactams and carbapenems.
    The Journal of antimicrobial chemotherapy, 2014, Volume: 69, Issue:3

    Topics: beta-Lactamases; beta-Lactams; Carbapenems; Enzyme Inhibitors; Escherichia coli Proteins; Kinetics; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Ultraviolet

2014
[Analysis of the carbapenemase-producing mechanism of Enterobacteriaceae with decreased susceptibility to carbapenems].
    Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2013, Volume: 33, Issue:11

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Enterobacteriaceae; Ertapenem; Gene Amplification; Imipenem; Meropenem; Microbial Sensitivity Tests; Polymerase Chain Reaction; Thienamycins

2013
In vivo efficacy of human simulated regimens of carbapenems and comparator agents against NDM-1-producing Enterobacteriaceae.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:3

    Topics: Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Disease Models, Animal; Doripenem; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Klebsiella pneumoniae; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests

2014
Efficacy of humanized carbapenem and ceftazidime regimens against Enterobacteriaceae producing OXA-48 carbapenemase in a murine infection model.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:3

    Topics: Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Ceftazidime; Disease Models, Animal; Doripenem; Ertapenem; Humans; Klebsiella pneumoniae; Levofloxacin; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests

2014
Use of outpatient parenteral antimicrobial therapy for transrectal ultrasound-guided prostate biopsy prophylaxis in the setting of community-associated multidrug-resistant Escherichia coli rectal colonization.
    Urology, 2014, Volume: 83, Issue:4

    Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotic Prophylaxis; beta-Lactams; Carbapenems; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Hospitalization; Humans; Image-Guided Biopsy; Infusions, Parenteral; Male; Middle Aged; Outpatients; Prevalence; Prospective Studies; Prostate; Prostatitis; Rectum; Ultrasonography, Interventional

2014
Biochemical analysis of metallo-β-lactamase NDM-3 from a multidrug-resistant Escherichia coli strain isolated in Japan.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:6

    Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Doripenem; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Japan; Microbial Sensitivity Tests; Plasmids

2014
Heteroresistance to carbapenems in New Delhi metallo-β-lactamase-1-producing isolates: a challenge for detection?
    Infection control and hospital epidemiology, 2014, Volume: 35, Issue:6

    Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Disease Susceptibility; Drug Resistance, Multiple; Enterobacteriaceae Infections; Ertapenem; Humans; Meropenem; Providencia; Thienamycins

2014
Effects of Group 1 versus Group 2 carbapenems on the susceptibility of Acinetobacter baumannii to carbapenems: a before and after intervention study of carbapenem-use stewardship.
    PloS one, 2014, Volume: 9, Issue:6

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Drug Resistance, Bacterial; Ertapenem; Humans; Microbial Sensitivity Tests

2014
Antimicrobial susceptibility and extended-spectrum beta-lactamase rates in aerobic gram-negative bacteria causing intra-abdominal infections in Vietnam: report from the Study for Monitoring Antimicrobial Resistance Trends (SMART 2009-2011).
    Diagnostic microbiology and infectious disease, 2014, Volume: 79, Issue:4

    Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Ertapenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intraabdominal Infections; Microbial Sensitivity Tests; Vietnam

2014
Kinetic study of the effect of histidines 240 and 164 on TEM-149 enzyme probed by β-lactam inhibitors.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:10

    Topics: beta-Lactamases; beta-Lactams; Carbapenems; Histidine; Kinetics; Penicillins

2014
Evaluation of inhibitory action of novel non β-lactam inhibitor against Klebsiella pneumoniae carbapenemase (KPC-2).
    PloS one, 2014, Volume: 9, Issue:9

    Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Cell Line; Ertapenem; HeLa Cells; Humans; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Protein Binding; Thienamycins

2014
Structure of ADC-68, a novel carbapenem-hydrolyzing class C extended-spectrum β-lactamase isolated from Acinetobacter baumannii.
    Acta crystallographica. Section D, Biological crystallography, 2014, Volume: 70, Issue:Pt 11

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Amino Acid Sequence; Bacterial Proteins; Base Sequence; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Crystallography, X-Ray; Humans; Models, Molecular; Molecular Sequence Data; Protein Conformation

2014
Kinetic and structural requirements for carbapenemase activity in GES-type β-lactamases.
    Biochemistry, 2015, Jan-20, Volume: 54, Issue:2

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Catalytic Domain; Crystallography, X-Ray; Doripenem; Ertapenem; Escherichia coli; Kinetics; Meropenem; Models, Molecular; Thienamycins

2015
Carbapenem susceptibility among Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae isolates obtained from patients in intensive care units in Taiwan in 2005, 2007, and 2009.
    Diagnostic microbiology and infectious disease, 2015, Volume: 81, Issue:4

    Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Enterobacter cloacae; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Escherichia coli; Hospitals, Teaching; Humans; Imipenem; Intensive Care Units; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Taiwan; Thienamycins

2015
Association between hypoalbuminemia and mortality among subjects treated with ertapenem versus other carbapenems: prospective cohort study.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2015, Volume: 21, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Hypoalbuminemia; Israel; Middle Aged; Prospective Studies; Risk Factors

2015
[Detection of serinocarbapenemases Class A and other mechanisms of enzymatic resistance to β-lactams in enterobacteria strains with diminished susceptibility to carbapenems isolated of patients in a university hospital].
    Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia, 2014, Volume: 31, Issue:6

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Chile; Enterobacteriaceae; Genotype; Hospitals, University; Humans; Microbial Sensitivity Tests; Phenotype

2014
Profiling of β-lactam selectivity for penicillin-binding proteins in Streptococcus pneumoniae D39.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:6

    Topics: Amdinocillin; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cephalosporins; Doripenem; Electrophoresis, Polyacrylamide Gel; Meropenem; Penicillin-Binding Proteins; Streptococcus pneumoniae; Thienamycins

2015
Identification of New Natural CphA Metallo-β-Lactamases CphA4 and CphA5 in Aeromonas veronii and Aeromonas hydrophila Isolates from Municipal Sewage in Central Italy.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:8

    Topics: Aeromonas hydrophila; Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Ertapenem; Imipenem; Italy; Molecular Sequence Data; Point Mutation; Sewage; Thienamycins

2015
Characterization of Multidrug Resistant Extended-Spectrum Beta-Lactamase-Producing Escherichia coli among Uropathogens of Pediatrics in North of Iran.
    BioMed research international, 2015, Volume: 2015

    Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Iran; Male; Urinary Tract Infections

2015
Consecutive radical S-adenosylmethionine methylations form the ethyl side chain in thienamycin biosynthesis.
    Proceedings of the National Academy of Sciences of the United States of America, 2015, Aug-18, Volume: 112, Issue:33

    Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Catalysis; Cephalosporins; Chromatography, Liquid; Cloning, Molecular; DNA Methylation; Drug Design; Escherichia coli; Fermentation; Methylation; Penicillins; S-Adenosylmethionine; Streptomyces; Tandem Mass Spectrometry; Thienamycins; Vitamin B 12

2015
Carbapenems and Rifampin Exhibit Synergy against Mycobacterium tuberculosis and Mycobacterium abscessus.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:10

    Topics: Antitubercular Agents; beta-Lactams; Carbapenems; Doripenem; Drug Synergism; Meropenem; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium tuberculosis; Rifampin; Thienamycins

2015
Antimicrobial resistance of Pseudomonas spp. isolated from wastewater and wastewater-impacted marine coastal zone.
    Environmental science and pollution research international, 2015, Volume: 22, Issue:24

    Topics: Anti-Infective Agents; beta-Lactams; Carbapenems; Colistin; Drug Resistance, Microbial; Environmental Monitoring; Fluoroquinolones; Microbial Sensitivity Tests; Oceans and Seas; Phylogeny; Poland; Pseudomonas; Seawater; Wastewater; Water Purification

2015
Role of efflux pumps inhibitor in decreasing antibiotic resistance of Klebsiella pneumoniae in a tertiary hospital in North India.
    Journal of infection in developing countries, 2015, Aug-29, Volume: 9, Issue:8

    Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Doripenem; Drug Resistance, Bacterial; Ertapenem; Genotype; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Minocycline; Polymerase Chain Reaction; Tigecycline

2015
Ertapenem-Containing Double-Carbapenem Therapy for Treatment of Infections Caused by Carbapenem-Resistant Klebsiella pneumoniae.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:1

    Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Carbapenems; Ertapenem; Female; Humans; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Male; Middle Aged; Pneumonia, Bacterial; Survival Analysis; Treatment Outcome; Urinary Tract Infections

2016
Camellia sinensis Ameliorates the Efficacy of Last Line Antibiotics Against Carbapenem Resistant Escherichia coli.
    Phytotherapy research : PTR, 2016, Volume: 30, Issue:2

    Topics: Amoxicillin-Potassium Clavulanate Combination; beta-Lactams; Camellia sinensis; Carbapenems; Colistin; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Flavonoids; Free Radical Scavengers; Meropenem; Microbial Sensitivity Tests; Minocycline; Phytochemicals; Plant Extracts; Plant Leaves; Thienamycins; Tigecycline

2016
[Analysis of carbapenems by hydrophilic interaction chromatography and its application].
    Se pu = Chinese journal of chromatography, 2015, Volume: 33, Issue:9

    Topics: beta-Lactams; Carbapenems; Chromatography; Doripenem; Drinking Water; Ertapenem; Humans; Hydrophobic and Hydrophilic Interactions; Meropenem; Thienamycins

2015
Severe Bloodstream Infection due to KPC-Producer E coli in a Renal Transplant Recipient Treated With the Double-Carbapenem Regimen and Analysis of In Vitro Synergy Testing: A Case Report.
    Medicine, 2016, Volume: 95, Issue:7

    Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Drug Synergism; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Kidney Transplantation; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Middle Aged; Surgical Wound Infection; Thienamycins

2016
Who should receive extended infusion beta-lactam therapy?
    JAAPA : official journal of the American Academy of Physician Assistants, 2016, Volume: 29, Issue:3

    Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbapenems; Cephalosporins; Drug Resistance, Bacterial; Humans; Infusions, Intravenous; Patient Selection; Penicillins

2016
[Investigation of carbapenemases in carbapenem-resistant Escherichia coli and Klebsiella pneumoniae strains isolated in 2014 in Turkey].
    Mikrobiyoloji bulteni, 2016, Volume: 50, Issue:1

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Proteins; Humans; Imipenem; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Multiplex Polymerase Chain Reaction; Phenotype; Thienamycins; Turkey

2016
A Multinational, Preregistered Cohort Study of β-Lactam/β-Lactamase Inhibitor Combinations for Treatment of Bloodstream Infections Due to Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:7

    Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Enterobacteriaceae; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Retrospective Studies

2016
Emergence of Serratia marcescens isolates possessing carbapenem-hydrolysing β-lactamase KPC-2 from China.
    The Journal of hospital infection, 2016, Volume: 94, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; China; DNA, Bacterial; Ertapenem; Female; Genotype; Hospitals; Humans; Hydrolysis; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Molecular Typing; Polymerase Chain Reaction; Serratia Infections; Serratia marcescens; Thienamycins; Young Adult

2016
Evaluation of different pretreatment protocols to detect accurately clinical carbapenemase-producing Enterobacteriaceae by MALDI-TOF.
    The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:10

    Topics: Acinetobacter; Anti-Bacterial Agents; Bacteria; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Clinical Laboratory Techniques; Enterobacter aerogenes; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Hydrolysis; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

2016
Comparison of the Modified-Hodge test, Carba NP test, and carbapenem inactivation method as screening methods for carbapenemase-producing Enterobacteriaceae.
    Journal of microbiological methods, 2016, Volume: 128

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Enterobacteriaceae; Ertapenem; Imipenem; Meropenem; Microbial Sensitivity Tests; Sensitivity and Specificity; Thienamycins

2016
Structural and Mutagenic Analysis of Metallo-β-Lactamase IMP-18.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:9

    Topics: beta-Lactamases; beta-Lactams; Carbapenems; Catalytic Domain; Kinetics; Meropenem; Mutagens; Pseudomonas aeruginosa; Thienamycins

2016
De-escalation of pivotal beta-lactam in ventilator-associated pneumonia does not impact outcome and marginally affects MDR acquisition.
    Intensive care medicine, 2016, Volume: 42, Issue:12

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Carbapenems; Drug Resistance, Multiple, Bacterial; Humans; Intensive Care Units; Pneumonia, Ventilator-Associated; Retrospective Studies

2016
1,3-Dipolar cycloaddition of a cyclic nitrone derived from 2-deoxy-D-ribose to α,β-unsaturated lactones: An entry to carbapenem antibiotics.
    Carbohydrate research, 2016, Oct-04, Volume: 433

    Topics: beta-Lactams; Carbapenems; Cycloaddition Reaction; Deoxyribose; Lactones; Molecular Structure; Nitrogen Oxides; Stereoisomerism

2016
Correlation between antimicrobial consumption and antimicrobial resistance of Pseudomonas aeruginosa in a hospital setting: a 10-year study.
    Journal of clinical pharmacy and therapeutics, 2016, Volume: 41, Issue:5

    Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Carbapenems; Drug Resistance, Bacterial; Drug Utilization; Gentamicins; Hospitals; Humans; Imipenem; Meropenem; Pseudomonas aeruginosa; Serbia; Thienamycins

2016
Antimicrobial-resistant Pseudomonas aeruginosa and Acinetobacter baumannii From Patients With Hospital-acquired or Ventilator-associated Pneumonia in Vietnam.
    Clinical therapeutics, 2016, Volume: 38, Issue:9

    Topics: Acinetobacter baumannii; Amikacin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Carbapenems; Cefepime; Cephalosporins; Cross Infection; Doripenem; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gentamicins; Humans; Longitudinal Studies; Microbial Sensitivity Tests; Minocycline; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Tigecycline; Vietnam

2016
Risk factors for hospital-acquired bacteremia due to carbapenem-resistant Pseudomonas aeruginosa in a Colombian hospital.
    Biomedica : revista del Instituto Nacional de Salud, 2016, Feb-23, Volume: 36, Issue:0

    Topics: Bacteremia; beta-Lactams; Carbapenems; Case-Control Studies; Ciprofloxacin; Drug Resistance, Bacterial; Ertapenem; Hospitals; Humans; Meropenem; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Thienamycins

2016
Transposition of Tn125 Encoding the NDM-1 Carbapenemase in Acinetobacter baumannii.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:12

    Topics: Acinetobacter baumannii; Bacterial Proteins; Base Composition; Base Sequence; beta-Lactamases; beta-Lactams; Carbapenems; DNA Transposable Elements; Humans; Microbial Sensitivity Tests

2016
Bulgecin A as a β-lactam enhancer for carbapenem-resistant
    Drug design, development and therapy, 2016, Volume: 10

    Topics: Acetylglucosamine; Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Enzyme Inhibitors; Proline; Pseudomonas aeruginosa

2016
Expanded Substrate Activity of OXA-24/40 in Carbapenem-Resistant Acinetobacter baumannii Involves Enhanced Binding Loop Flexibility.
    Biochemistry, 2016, Nov-29, Volume: 55, Issue:47

    Topics: Acinetobacter baumannii; Amino Acid Motifs; Amino Acid Sequence; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Magnetic Resonance Spectroscopy; Models, Molecular; Mutation; Pliability; Protein Binding; Protein Domains; Protein Structure, Secondary; Substrate Specificity

2016
Phenotypic and molecular detection of the bla
    BMC infectious diseases, 2016, 12-07, Volume: 16, Issue:1

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Brazil; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Hospitals; Humans; Inpatients; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Epidemiology; Polymerase Chain Reaction; Pseudomonas aeruginosa

2016
Antimicrobial susceptibility of Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Asia-Pacific countries: SMART 2013-2015.
    Journal of medical microbiology, 2017, Volume: 66, Issue:1

    Topics: Acinetobacter baumannii; Amikacin; Anti-Infective Agents; Asia; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacter; Ertapenem; Gram-Negative Bacteria; Hospitalization; Humans; Imipenem; Intraabdominal Infections; Klebsiella pneumoniae; Levofloxacin; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Urinary Tract Infections

2017
Binding and processing of β-lactam antibiotics by the transpeptidase Ldt
    The FEBS journal, 2017, Volume: 284, Issue:5

    Topics: beta-Lactams; Carbapenems; Crystallography, X-Ray; Kinetics; Mycobacterium tuberculosis; Peptidoglycan; Peptidyl Transferases; Protein Conformation; Tuberculosis

2017
E152A substitution drastically affects NDM-5 activity.
    FEMS microbiology letters, 2017, 02-01, Volume: 364, Issue:3

    Topics: Amino Acid Substitution; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Catalytic Domain; Drug Resistance, Multiple, Bacterial; Escherichia coli; Glutamic Acid; Hydrolysis; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Mutation

2017
Development of an algorithm for phenotypic screening of carbapenemase-producing Enterobacteriaceae in the routine laboratory.
    BMC infectious diseases, 2017, 01-17, Volume: 17, Issue:1

    Topics: Algorithms; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Cefepime; Cephalosporins; Clavulanic Acids; Drug Resistance, Bacterial; Enterobacteriaceae; Ertapenem; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Tazobactam; Thienamycins; Ticarcillin

2017
Epidemiology and susceptibility of pathogens from SMART 2011-12 Turkey: evaluation of hospital-acquired versus community-acquired urinary tract infections and ICU- versus non-ICU-associated intra-abdominal infections.
    The Journal of antimicrobial chemotherapy, 2017, 05-01, Volume: 72, Issue:5

    Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cefoxitin; Community-Acquired Infections; Cross Infection; Enterobacteriaceae; Ertapenem; Escherichia coli; Humans; Imipenem; Intensive Care Units; Intraabdominal Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Turkey; Urinary Tract Infections

2017
Occurrence of bla
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2017, Volume: 23, Issue:4

    Topics: Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Conjugation, Genetic; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; India; Plasmids

2017
Antibacterial activity of epigallocatechin-3-gallate (EGCG) and its synergism with β-lactam antibiotics sensitizing carbapenem-associated multidrug resistant clinical isolates of Acinetobacter baumannii.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2017, Jan-15, Volume: 24

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Catechin; Drug Resistance, Multiple; Humans; Microbial Sensitivity Tests; Phytotherapy; Plant Extracts

2017
Carbapenem MICs in Escherichia coli and Klebsiella Species Producing Extended-Spectrum β-Lactamases in Critical Care Patients from 2001 to 2009.
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:4

    Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Critical Care; Doripenem; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Gene Expression; Genotype; Humans; Imipenem; Klebsiella; Klebsiella Infections; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Thienamycins; United States

2017
Combinations of avibactam and carbapenems exhibit enhanced potencies against drug-resistant Mycobacterium abscessus.
    Future microbiology, 2017, Volume: 12

    Topics: Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactams; Carbapenems; Drug Resistance, Multiple, Bacterial; Ertapenem; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Thienamycins

2017
IMI-2 carbapenemase in a clinical Klebsiella variicola isolated in the UK.
    The Journal of antimicrobial chemotherapy, 2017, 07-01, Volume: 72, Issue:7

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; Drug Resistance, Bacterial; Ertapenem; Gene Transfer, Horizontal; Humans; Imipenem; Klebsiella; Meropenem; Plasmids; Thienamycins; United Kingdom

2017
Differential flap dynamics in l,d-transpeptidase2 from mycobacterium tuberculosis revealed by molecular dynamics.
    Molecular bioSystems, 2017, Jun-01, Volume: 13, Issue:6

    Topics: beta-Lactams; Carbapenems; Ertapenem; Imipenem; Meropenem; Molecular Dynamics Simulation; Mycobacterium tuberculosis; Principal Component Analysis; Thienamycins

2017
In vitro susceptibility and resistance phenotypes in contemporary Enterobacter isolates in a university hospital in Crete, Greece.
    Future microbiology, 2017, Volume: 12

    Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Cefepime; Cephalosporins; Child; Colistin; Drug Resistance, Multiple, Bacterial; Enterobacter; Enterobacteriaceae Infections; Greece; Hospitals, University; Humans; Microbial Sensitivity Tests; Minocycline; Penicillanic Acid; Phenotype; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tigecycline

2017
Structural insight into the inactivation of Mycobacterium tuberculosis non-classical transpeptidase Ldt
    BMC biochemistry, 2017, 05-25, Volume: 18, Issue:1

    Topics: beta-Lactams; Carbapenems; Crystallography, X-Ray; Drug Design; Mycobacterium tuberculosis; Peptidyl Transferases; Protein Binding; Thienamycins

2017
Ldt
    Future microbiology, 2017, Volume: 12

    Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Crystallography, X-Ray; Drug Resistance, Multiple, Bacterial; Genome, Bacterial; Mycobacterium avium Complex; Peptidyl Transferases; Sequence Analysis, DNA

2017
Drug allergy evaluation for betalactam hypersensitivity: Cross-reactivity with cephalosporines, carbapenems and negative predictive value.
    Asian Pacific journal of allergy and immunology, 2018, Volume: 36, Issue:1

    Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cephalosporins; Child; Cross Reactions; Drug Hypersensitivity; Female; Humans; Male; Middle Aged; Penicillins; Predictive Value of Tests; Skin Tests

2018
Efficacy of β-Lactam/β-Lactamase Inhibitor Combinations for the Treatment of Bloodstream Infection Due to Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae in Hematological Patients with Neutropenia.
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:8

    Topics: Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Cohort Studies; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Neutropenia

2017
Cumulative Effect of an Antimicrobial Stewardship and Rapid Diagnostic Testing Bundle on Early Streamlining of Antimicrobial Therapy in Gram-Negative Bloodstream Infections.
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:9

    Topics: Adolescent; Anti-Bacterial Agents; Antimicrobial Stewardship; Bacteremia; beta-Lactams; Blood Culture; Carbapenems; Gram-Negative Bacteria; Humans; Prospective Studies

2017
ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii.
    Nature microbiology, 2017, Jun-30, Volume: 2

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Dogs; Drug Design; Drug Evaluation, Preclinical; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Mice; Models, Molecular; Penicillin-Binding Proteins; Rats; Sulbactam

2017
Thiol-Containing Metallo-β-Lactamase Inhibitors Resensitize Resistant Gram-Negative Bacteria to Meropenem.
    ACS infectious diseases, 2017, 10-13, Volume: 3, Issue:10

    Topics: beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Cefoperazone; Drug Resistance, Bacterial; Gram-Negative Bacteria; Meropenem; Molecular Structure; Sulfhydryl Compounds; Thienamycins

2017
Reducing Carbapenem Exposure: Extended-Spectrum β-Lactamase Catheter-Associated Urinary Tract Infection Management.
    Critical care nurse, 2017, Volume: 37, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Carbapenems; Enterobacteriaceae; Female; Humans; Male; Middle Aged; United States; Urinary Tract Infections

2017
The use of cefepime as a carbapenem-sparing antibiotic for treating uncomplicated acute pyelonephritis caused by extended-spectrum β-lactamase producing Escherichia coli.
    Infectious diseases (London, England), 2018, Volume: 50, Issue:3

    Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Cefepime; Cephalosporins; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Hospitals, University; Humans; Male; Middle Aged; Pyelonephritis; Republic of Korea; Retrospective Studies; Risk Factors; Treatment Outcome

2018
Copper Ions and Coordination Complexes as Novel Carbapenem Adjuvants.
    Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:2

    Topics: Adjuvants, Pharmaceutic; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Coordination Complexes; Copper; Ertapenem; Escherichia coli; Humans; Ions; Meropenem; Microbial Sensitivity Tests; Urinary Tract Infections

2018
A nitrocefin disc supplemented with ertapenem for rapid screening of carbapenemase-producing Enterobacteriaceae.
    Diagnostic microbiology and infectious disease, 2018, Volume: 91, Issue:1

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; Disk Diffusion Antimicrobial Tests; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Microbial Sensitivity Tests; Sensitivity and Specificity

2018
Global survey of Klebsiella pneumoniae major porins from ertapenem non-susceptible isolates lacking carbapenemases.
    Journal of medical microbiology, 2018, Volume: 67, Issue:3

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; DNA, Bacterial; Electrophoresis, Polyacrylamide Gel; Ertapenem; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Mutation; Porins

2018
Novel variant NDM-11 and other NDM-1 variants in multidrug-resistant Escherichia coli from South India.
    Journal of global antimicrobial resistance, 2018, Volume: 14

    Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; beta-Lactams; Carbapenems; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Genetic Variation; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids; Snake Bites; Wound Infection

2018
Phylogenomic Analysis of β-Lactamase in Archaea and Bacteria Enables the Identification of Putative New Members.
    Genome biology and evolution, 2018, 04-01, Volume: 10, Issue:4

    Topics: Anti-Bacterial Agents; Archaea; Bacteria; beta-Lactamases; beta-Lactams; Carbapenems; Humans; Metagenomics; Phylogeny

2018
Rapid detection of carbapenemase activity of Enterobacteriaceae isolated from positive blood cultures by MALDI-TOF MS.
    Annals of clinical microbiology and antimicrobials, 2018, May-18, Volume: 17, Issue:1

    Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; beta-Lactams; Blood Culture; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Ertapenem; Humans; Hydrolysis; Microbial Sensitivity Tests; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

2018
Inferring Antimicrobial Resistance from Pathogen Genomes in KEGG.
    Methods in molecular biology (Clifton, N.J.), 2018, Volume: 1807

    Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Databases, Genetic; Drug Resistance, Bacterial; Genome, Bacterial; Phylogeny

2018
Genetic and Biochemical Characterization of OXA-535, a Distantly Related OXA-48-Like β-Lactamase.
    Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:10

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Chromosomes, Bacterial; Microbial Sensitivity Tests; Plasmids; Shewanella

2018
Comparison of empirical therapy with cefoperazone/sulbactam or a carbapenem for bloodstream infections due to ESBL-producing Enterobacteriaceae.
    The Journal of antimicrobial chemotherapy, 2018, 11-01, Volume: 73, Issue:11

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Case-Control Studies; Cefoperazone; China; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Sulbactam

2018
Antibiotics associated with acquisition of carbapenem-resistant Pseudomonas aeruginosa in ICUs: a multicentre nested case-case-control study.
    The Journal of antimicrobial chemotherapy, 2019, 02-01, Volume: 74, Issue:2

    Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Case-Control Studies; Drug Resistance, Multiple, Bacterial; Female; Hospitalization; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Models, Statistical; Prospective Studies; Pseudomonas aeruginosa; Risk Factors

2019
Novel Antibiotics in the Treatment of Urinary Tract Infections.
    European urology focus, 2019, Volume: 5, Issue:1

    Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Clinical Trials as Topic; Cystitis; Drug Resistance, Bacterial; Drug Therapy, Combination; Drug Utilization; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Iatrogenic Disease; Tetracyclines; Urinary Tract Infections

2019
    Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:3

    Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactams; Boronic Acids; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous

2019
Evaluation of Susceptibilities to Carbapenems and Faropenem Against Cephalosporin-Resistant Neisseria gonorrhoeae Clinical Isolates with penA Mosaic Alleles.
    Microbial drug resistance (Larchmont, N.Y.), 2019, Volume: 25, Issue:3

    Topics: Alleles; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Carbapenems; Cephalosporin Resistance; Cephalosporins; Humans; Male; Microbial Sensitivity Tests; Mutation; Neisseria gonorrhoeae

2019
Modeling Ertapenem: the impact of body mass index on distribution of the antibiotic in the body.
    Mathematical biosciences and engineering : MBE, 2019, 01-15, Volume: 16, Issue:2

    Topics: Algorithms; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Body Mass Index; Body Weight; Carbapenems; Computer Simulation; Drug Administration Schedule; Ertapenem; Female; Humans; Male; Models, Theoretical; Obesity; Thinness

2019
Anti-ESBL investigation of chitosan/silver nanocomposites against carbapenem resistant Pseudomonas aeruginosa.
    International journal of biological macromolecules, 2019, Jul-01, Volume: 132

    Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Chitosan; Drug Resistance, Bacterial; Metal Nanoparticles; Microbial Sensitivity Tests; Nanocomposites; Pseudomonas aeruginosa; Silver

2019
Comparison of adhesin genes expression among Klebsiella oxytoca ESBL-non-producers in planktonic and biofilm mode of growth, and imipenem sublethal exposure.
    Microbial pathogenesis, 2019, Volume: 134

    Topics: Adhesins, Bacterial; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Biofilms; Carbapenems; Gene Expression Regulation, Bacterial; Genes, Bacterial; Humans; Imipenem; Klebsiella Infections; Klebsiella oxytoca; Microbial Sensitivity Tests; Phenotype

2019
Changing epidemiology of KPC-producing Klebsiella pneumoniae in Argentina: Emergence of hypermucoviscous ST25 and high-risk clone ST307.
    Journal of global antimicrobial resistance, 2019, Volume: 18

    Topics: Argentina; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; beta-Lactams; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Typing; Multilocus Sequence Typing; Plasmids

2019
Identification of Mutations in the
    mSphere, 2019, 07-03, Volume: 4, Issue:4

    Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Escherichia coli; Escherichia coli Proteins; Microbial Sensitivity Tests; Mutation; Penicillin-Binding Proteins; Peptidoglycan Glycosyltransferase

2019
Induction of plasmid-mediated AmpC β-lactamase DHA-1 by piperacillin/tazobactam and other β-lactams in Enterobacteriaceae.
    PloS one, 2019, Volume: 14, Issue:7

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Citrobacter freundii; Enterobacter cloacae; Enterobacteriaceae; Escherichia coli; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Piperacillin, Tazobactam Drug Combination; Plasmids; Serratia marcescens

2019
Antibiotic Exposure Profiles in Trials Comparing Intensity of Continuous Renal Replacement Therapy.
    Critical care medicine, 2019, Volume: 47, Issue:11

    Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Clinical Trials as Topic; Computer Simulation; Continuous Renal Replacement Therapy; Critical Illness; Dose-Response Relationship, Drug; Humans; Models, Biological; Monte Carlo Method

2019
New Trimodal Phenotypic Reporter of Extended-Spectrum β-Lactamase Activity.
    ACS infectious diseases, 2019, 10-11, Volume: 5, Issue:10

    Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamases; beta-Lactams; Biosensing Techniques; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Oxazines; Sulfides

2019
Direct medical costs of urinary tract infections by Gram-negative bacilli resistant to beta-lactams in a tertiary care hospital in Medellín, Colombia
    Biomedica : revista del Instituto Nacional de Salud, 2019, 05-01, Volume: 39, Issue:s1

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Carbapenems; Cephalosporins; Cohort Studies; Colombia; Cross Infection; Diagnostic Imaging; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacteria; Health Expenditures; Hospitalization; Hospitals, Urban; Humans; Male; Middle Aged; Tertiary Care Centers; Urinary Tract Infections

2019
Genomic analysis of a pan-resistant Klebsiella pneumoniae sequence type 11 identified in Japan in 2016.
    International journal of antimicrobial agents, 2020, Volume: 55, Issue:4

    Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Japan; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids; Whole Genome Sequencing

2020
Higher rates of carbapenem-related seizures in older hospitalised adults.
    Internal medicine journal, 2020, Volume: 50, Issue:1

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Ertapenem; Female; Hospitalization; Humans; Imipenem; Logistic Models; Male; Meropenem; Seizures; Singapore

2020
Faropenem resistance causes in vitro cross-resistance to carbapenems in ESBL-producing Escherichia coli.
    International journal of antimicrobial agents, 2020, Volume: 55, Issue:3

    Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Porins

2020
Novel Cassette Assay To Quantify the Outer Membrane Permeability of Five β-Lactams Simultaneously in Carbapenem-Resistant
    mBio, 2020, 02-11, Volume: 11, Issue:1

    Topics: Anti-Bacterial Agents; Bacterial Outer Membrane; beta-Lactams; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cell Membrane Permeability; Enterobacter cloacae; Klebsiella pneumoniae; Microbial Sensitivity Tests

2020
Structure and Molecular Recognition Mechanism of IMP-13 Metallo-β-Lactamase.
    Antimicrobial agents and chemotherapy, 2020, 05-21, Volume: 64, Issue:6

    Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems

2020
Impact of removing ESBL designation from culture reports on the selection of antibiotics for the treatment of infections associated with ESBL-producing organisms.
    Infection control and hospital epidemiology, 2020, Volume: 41, Issue:5

    Topics: Academic Medical Centers; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Drug Utilization; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Philadelphia; Retrospective Studies

2020
    ACS infectious diseases, 2020, 06-12, Volume: 6, Issue:6

    Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Carbapenems; Pharmaceutical Preparations

2020
The Effect of Beta-lactam Allergy Status on the Rate of Surgical Site Infections: A Retrospective Cohort Study.
    Annals of surgery, 2022, 01-01, Volume: 275, Issue:1

    Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactams; Carbapenems; Cefazolin; Cephalosporins; Drug Hypersensitivity; Female; Humans; Male; Middle Aged; Penicillins; Retrospective Studies; Risk Factors; Surgical Wound Infection

2022
4-(
    Biomolecules, 2020, 07-23, Volume: 10, Issue:8

    Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Biocatalysis; Carbapenems; Drug Resistance, Bacterial; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Molecular Structure; Thiones; Triazoles

2020
Neo-antigens for the serological diagnosis of IgE-mediated drug allergic reactions to antibiotics cephalosporin, carbapenem and monobactam.
    Scientific reports, 2020, 09-29, Volume: 10, Issue:1

    Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactams; Carbapenems; Cefotaxime; Ceftriaxone; Cefuroxime; Cephalosporins; Cross Reactions; Drug Hypersensitivity; Humans; Immunoglobulin E; Immunoglobulin G; Meropenem; Monobactams; Penicillins; Skin Tests

2020
The paradoxical in vivo activity of β-lactams against metallo-β-lactamase-producing Enterobacterales is not restricted to carbapenems.
    The Journal of antimicrobial chemotherapy, 2021, 02-11, Volume: 76, Issue:3

    Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Mice; Microbial Sensitivity Tests

2021
Risk comparison of beta-lactam-induced anaphylaxis: Therapeutic stratification analysis in a Vietnamese pharmacovigilance database.
    Journal of clinical pharmacy and therapeutics, 2021, Volume: 46, Issue:4

    Topics: Age Factors; Anaphylaxis; Anti-Bacterial Agents; Asian People; beta-Lactams; Carbapenems; Cephalosporins; Drug Therapy, Combination; Humans; Penicillins; Pharmacovigilance; Risk Factors; Sex Factors; Vietnam

2021
Click and Release Chemistry for Activity-Based Purification of β-Lactam Targets.
    Chemistry (Weinheim an der Bergstrasse, Germany), 2021, May-17, Volume: 27, Issue:28

    Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Click Chemistry; Penicillin-Binding Proteins; Peptidoglycan; Peptidyl Transferases

2021
Biochemical characterization of OXA-244, an emerging OXA-48 variant with reduced β-lactam hydrolytic activity.
    The Journal of antimicrobial chemotherapy, 2021, 07-15, Volume: 76, Issue:8

    Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Escherichia coli; Escherichia coli Proteins; Hydrolysis; Microbial Sensitivity Tests

2021
Role of AmpG in the resistance to β-lactam agents, including cephalosporins and carbapenems: candidate for a novel antimicrobial target.
    Annals of clinical microbiology and antimicrobials, 2021, Jun-16, Volume: 20, Issue:1

    Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactams; Carbapenems; Cephalosporins; CRISPR-Cas Systems; Democratic People's Republic of Korea; DNA Transposable Elements; Gene Expression Regulation, Bacterial; Gene Knockout Techniques; Humans; Klebsiella pneumoniae; Membrane Transport Proteins; Microbial Sensitivity Tests; Mutagenesis; Sequence Alignment

2021
Activity of β-lactam plus β-lactam-enhancer combination cefepime/zidebactam against Klebsiella pneumoniae harbouring defective OmpK35/36 porins and carbapenemases.
    Diagnostic microbiology and infectious disease, 2021, Volume: 101, Issue:2

    Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Cyclooctanes; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Mutation; Porins

2021
A novel tricyclic β-lactam exhibiting potent antibacterial activities against carbapenem-resistant Enterobacterales: Synthesis and structure-activity-relationships.
    Bioorganic & medicinal chemistry, 2021, 09-15, Volume: 46

    Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Enterobacteriaceae; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship

2021
Probable Encephalopathy and Spasticity in a Multiple Sclerosis Patient Following Carbapenem Administration: A Case Report and Brief Literature Review.
    Journal of pharmacy practice, 2023, Volume: 36, Issue:3

    Topics: Anti-Bacterial Agents; beta-Lactams; Brain Diseases; Carbapenems; Female; Humans; Middle Aged; Multiple Sclerosis

2023
Rescuing Tetracycline Class Antibiotics for the Treatment of Multidrug-Resistant Acinetobacter baumannii Pulmonary Infection.
    mBio, 2022, 02-22, Volume: 13, Issue:1

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; beta-Lactams; Carbapenems; COVID-19; Drug Resistance, Multiple, Bacterial; Humans; Mice; Microbial Sensitivity Tests; Pandemics; Pneumonia, Ventilator-Associated; Tetracycline; Tigecycline; Zinc

2022
Discovery of a Tricyclic β-Lactam as a Potent Antimicrobial Agent against Carbapenem-Resistant Enterobacterales, Including Strains with Reduced Membrane Permeability and Four-Amino Acid Insertion into Penicillin-Binding Protein 3: Structure-Activity-Relat
    ACS infectious diseases, 2022, 03-11, Volume: 8, Issue:3

    Topics: Amino Acids; Animals; beta-Lactamase Inhibitors; beta-Lactams; Carbapenems; Mice; Microbial Sensitivity Tests; Penicillin-Binding Proteins; Permeability

2022
Comparative bactericidal activity of representative β-lactams against Enterobacterales, Acinetobacter baumannii and Pseudomonas aeruginosa.
    The Journal of antimicrobial chemotherapy, 2022, 04-27, Volume: 77, Issue:5

    Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Aztreonam; beta-Lactams; Carbapenems; Ceftazidime; Cephalosporins; Escherichia coli; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Monobactams; Piperacillin; Pseudomonas aeruginosa; Tazobactam

2022
Featured Article Editorial: Discovery of a Tricyclic β-Lactam Active against Carbapenem-Resistant Enterobacterales.
    ACS infectious diseases, 2022, 03-11, Volume: 8, Issue:3

    Topics: beta-Lactamases; beta-Lactams; Carbapenems; Microbial Sensitivity Tests

2022
Prevalence and molecular characterization of foodborne and human-derived Salmonella strains for resistance to critically important antibiotics.
    Transboundary and emerging diseases, 2022, Volume: 69, Issue:5

    Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Cattle; Cephalosporins; Ciprofloxacin; Colistin; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Monobactams; Prevalence; Rabbits; Salmonella; Salmonella enterica; Tetracyclines

2022
Uncovering Beta-Lactam Susceptibility Patterns in Clinical Isolates of Mycobacterium tuberculosis through Whole-Genome Sequencing.
    Microbiology spectrum, 2022, 08-31, Volume: 10, Issue:4

    Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Peptidoglycan; Tuberculosis

2022
QM/MM Simulations Reveal the Determinants of Carbapenemase Activity in Class A β-Lactamases.
    ACS infectious diseases, 2022, 08-12, Volume: 8, Issue:8

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Gram-Negative Bacteria; Molecular Dynamics Simulation

2022
Using Culture-Enriched Phenotypic Metagenomics for Targeted High-Throughput Monitoring of the Clinically Important Fraction of the β-Lactam Resistome.
    Environmental science & technology, 2022, 08-16, Volume: 56, Issue:16

    Topics: Anti-Bacterial Agents; Bacteria; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Metagenomics; Microbial Sensitivity Tests; Water Purification

2022
Genomic characterization of BKC-1-producing Klebsiella pneumoniae strain belonging to high-risk clone sequence type 11 isolated from a river in Brazil.
    The Science of the total environment, 2022, Dec-01, Volume: 850

    Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Brazil; Carbapenems; Clone Cells; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Genomics; Humans; Klebsiella; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Polymyxins; Rivers; Siderophores; Type VI Secretion Systems

2022
Evolution of antibiotic treatments for healthcare-associated infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae in France.
    Infectious diseases now, 2022, Volume: 52, Issue:7

    Topics: Aminoglycosides; Amoxicillin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Clavulanic Acid; Cross Infection; Delivery of Health Care; Enterobacteriaceae; Enterobacteriaceae Infections; France; Humans; Nitrofurantoin; Ofloxacin; Penicillins; Urinary Tract Infections

2022
Strongly Bactericidal All-Oral β-Lactam Combinations for the Treatment of Mycobacterium abscessus Lung Disease.
    Antimicrobial agents and chemotherapy, 2022, 09-20, Volume: 66, Issue:9

    Topics: Amoxicillin; Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Cefuroxime; Humans; Lactams; Lung Diseases; Microbial Sensitivity Tests; Mycobacterium abscessus

2022
Proteomics profiling of ertapenem challenged major porin deficient carbapenem-resistant Klebsiella pneumoniae.
    Journal of proteomics, 2022, 09-30, Volume: 268

    Topics: Anti-Bacterial Agents; Antioxidants; ATP-Binding Cassette Transporters; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Ertapenem; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Porins; Proteomics

2022
Beta-lactam hypersensitivity diagnosis in ambulatory and hospitalized settings require different approaches.
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2023, Volume: 130, Issue:1

    Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cephalosporins; Cross Reactions; Drug Hypersensitivity; Humans; Hypersensitivity, Immediate; Penicillins; Skin Tests

2023
Computational and data mining studies to understand the distribution and dynamics of Temoneria (TEM) β-lactamase and their interaction with β-lactam and β-lactamase inhibitors.
    Environmental pollution (Barking, Essex : 1987), 2022, Dec-01, Volume: 314

    Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Data Mining; Molecular Docking Simulation; Monobactams; Penicillins; Tazobactam

2022
Effects of reported beta-lactam allergies on pneumonia outcomes in lung transplant recipients.
    Transplant infectious disease : an official journal of the Transplantation Society, 2022, Volume: 24, Issue:5

    Topics: Acute Kidney Injury; Anti-Bacterial Agents; Aztreonam; beta-Lactams; Carbapenems; Clostridium Infections; Drug Hypersensitivity; Fluoroquinolones; Humans; Hypersensitivity; Lung; Pneumonia; Retrospective Studies; Transplant Recipients

2022
Ertapenem-induced neurotoxicity in an end-stage renal disease patient on intermittent haemodialysis: a case report.
    BMC nephrology, 2022, 11-08, Volume: 23, Issue:1

    Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Ertapenem; Humans; Kidney Failure, Chronic; Male; Middle Aged; Neurotoxicity Syndromes; Renal Dialysis; Renal Insufficiency, Chronic

2022
Comparison of the relative efficacy of β-lactam/β-lactamase inhibitors and carbapenems in the treatment of complicated urinary tract infections caused by ceftriaxone-non-susceptible Enterobacterales: a multicentre retrospective observational cohort study.
    The Journal of antimicrobial chemotherapy, 2023, 03-02, Volume: 78, Issue:3

    Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Ceftriaxone; Enterobacteriaceae; Enterobacteriaceae Infections; Gammaproteobacteria; Humans; Lactams; Retrospective Studies; Urinary Tract Infections

2023
Evaluation of Oral Tebipenem as a Step-Down Therapy following Intravenous Ertapenem against Extended-Spectrum β-Lactamase-Producing Escherichia coli in a Hollow-Fiber
    Antimicrobial agents and chemotherapy, 2023, 03-16, Volume: 67, Issue:3

    Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Ertapenem; Escherichia coli; Humans

2023
A conserved zinc-binding site in
    Proceedings of the National Academy of Sciences of the United States of America, 2023, 02-21, Volume: 120, Issue:8

    Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Binding Sites; Carbapenems; Cell Shape; Chelating Agents; Penicillin-Binding Proteins; Peptidyl Transferases; Zinc

2023
Interactions of hydrolyzed β-lactams with the L1 metallo-β-lactamase: Crystallography supports stereoselective binding of cephem/carbapenem products.
    The Journal of biological chemistry, 2023, Volume: 299, Issue:5

    Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Crystallography; Gram-Negative Bacterial Infections; Humans; Kinetics; Stenotrophomonas maltophilia

2023
Phenotypic and molecular characterization of beta-lactam resistant Multidrug-resistant Enterobacterales isolated from patients attending six hospitals in Northern Nigeria.
    Scientific reports, 2023, 06-26, Volume: 13, Issue:1

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Escherichia coli; Hospitals; Humans; Microbial Sensitivity Tests; Nigeria

2023
Antibiotic Consumption During the Coronavirus Disease 2019 Pandemic and Emergence of Carbapenemase-Producing Klebsiella pneumoniae Lineages Among Inpatients in a Chilean Hospital: A Time-Series Study and Phylogenomic Analysis.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2023, 07-05, Volume: 77, Issue:Suppl 1

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Chile; Colistin; COVID-19; Hospitals; Humans; Inpatients; Klebsiella pneumoniae; Microbial Sensitivity Tests; Pandemics; Phylogeny

2023